Certified French language Translation of Reasons for Judgment and Judgment rendered on 15-FEB-2018 by The Honourable Mr. Justice Locke filed on 21-JUL-2021 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of Judgment entered in J. & O. Book, volume 1501 page(s) 293 - 295 and copy placed on file.

Discontinuance with Consent (Copy - original filed on Court File No. A-92-18 ) on behalf of Appellant with consent on behalf of Respondent filed on 25-JUN-2018

Letter from Defendant (AstraZeneca) dated 27-JUN-2018 (re: direction of the Court dated 08-MAY-2018) advising, on consent, that the parties have resolved the issue on costs and that the Court's assistance is no longer needed. -scanned to Justice Locke- received on 27-JUN-2018

Reasons Judgment and Reasons (PUBLIC VERSION) dated 15-FEB-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: "THIS COURT'S JUDGMENT is that: 1. Apotex Inc.'s (Apotex's) claim in Court File No. T-389-11 is dismissed. 2. As regards Court File No. T-1668-10: a. The making, using and selling by Apotex Pharmachem Inc., prior to the expiry of Canadian Patent No. 2,193,994 (the 994 Patent), of esomeprazole magnesium made by a process that employs the titanium catalyst infringes the 994 Patent save and except for such making, using and selling that qualifies for the experimental and regulatory use exemptions to infringement ,the latter to be determined by the Court at a further hearing; and b. The using by Apotex, prior to the expiry of the 994 Patent, of esomeprazole magnesium made by a process that employs the titanium catalyst infringes the 994 Patent save and except for such using that qualifies for the experimental and regulatory use exemptions to infringement , the latter to be determined by the Court at a further hearing. 3. Apotex shall pay AstraZeneca Canada Inc.¿s (AstraZeneca¿s) costs of the trial. If the parties are unable to agree on the quantum of costs, AstraZeneca shall serve and file its costs submissions, of no more than 12 pages, within 30 days following the date of this decision. Apotex shall have 15 days following receipt of AstraZeneca¿s submissions to serve and file its responding costs submissions which shall be limited to 15 pages. Thereafter, AstraZeneca may, within five (5) days following receipt of Apotex¿s responding submissions, serve and file reply costs submissions of no more than three (3) pages." Filed on 15-FEB-2018 copies sent to parties Final Decision Certificate of Judgment and Reasons entered in J. & O. Book, volume 1371 page(s) 299 - 300

Certified French language Translation of JUDGMENT AND REASONS rendered on 15-FEB-2018 by The Honourable Mr. Justice Locke filed on 15-MAY-2018 pursuant to s. 20 of the Official Languages Act. Certificate of Translation of JUDGMENT AND REASONS entered in J. & O. Book, volume 1369 page(s) 324 - 325 and copy placed on file.

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 08-MAY-2018 directing that "Agress to the parties' joint proposal." placed on file on 08-MAY-2018

Letter from Defendant dated 04-MAY-2018 re: Seeking abeyance of deadlines set in letter dated April 5, 2018.. Scanned to Locke, J.) received on 04-MAY-2018

Acknowledgment of Receipt received from Plaintiff with respect to ID 413 placed on file on 24-APR-2018

Acknowledgment of Receipt received from Defendant with respect to ID 413 placed on file on 24-APR-2018

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 23-APR-2018 directing that "Further to the letter from the parties dated 06-APR-2018, the Court grants: a)The request that the following trial exhibits remain confidential: P-2, P-3 (except Tab 16), D-5, D-13, D-14, D-15, D-16, D-17, D-18, D-19 D-20, D-21, D-22, D-23, D-24, D-25, D-26, D-30, D-31, D-32, D-33, D-34 D-35, P-38, D-39, D-40, P-42, P-43, P-45 (except Tabs 6-9), D-46 P-48, (Tabs 1-5, 7-8), P-53 (paras 35-36 and Table 1, 38 and underlying figures, 58 and Schedule 3) D-54, P-57, P-59, P-60, P-62 (paras 74-75, 90-91), D-81, P-82 (except PDF pages 34-36); b) The request that only the redacted versions of Trial Transcripts, Vols. 1, 2, 4, 5, 7, 8, 10, 11, 13, 14 and 15 be made available to the public; and c) the request that the opening and closing briefs remain confidential." placed on file on 24-APR-2018

Letter from Plaintiff dated 09-APR-2018 advising which exhibits (and other material) be maintained confidential providing a USB key containing redacted versions of transcripts & duplicate set of proposed redactions. ***1 USB WITH JUDGE'S COPY OF LETTER ONLY*** received on 09-APR-2018

Letter from Defendant dated 05-APR-2018 "We are counsel for AstraZeneca parties in the above referenced proceedings. Kindly bring this letter to the attention of Mr. Justice Locke. We write further to Mr. Justice Locke's Direction dated March 9, 2018, which granted AstraZeneca's request to extend the deadline to serve and file its costs submissions to APril 6, 2018. We write with consent of counsel for Apotex Inc. to request that the parties' cost submissions deadlines be extended as follows..." (Scanned to Locke, J.) received on 05-APR-2018

Copy of Notice of Appeal on behalf of Plaintiff dated 19-MAR-2018 placed on file on 26-MAR-2018 Original filed on Court File No. A-92-18

Acknowledgment of Receipt received from BOTH PARTIES (BY EMAIL) with respect to Directions of the Court (Locke, J.) dated 23-FEB-2018 placed on file on 05-MAR-2018

Acknowledgment of Receipt received from Mr. Koo and Mr. Topolski with respect to Direction ID#407, by email placed on file on 12-MAR-2018

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 12-MAR-2018 directing that "Having read and considered the submissions of the parties dated February 22, February 28 and March 5, 2018, the Court concludes that the redactions from the public version of the Court's decision dated February 16, 2018 (2018 FC 181), requested by Apotex Inc. (Apotex) and Apotex Pharmachem Inc. (Pharmachem) will not be made. The two words that are the subject of the requested redactions, and which describe Pharmachem's manufacturing process, have been on the public record at least since March 10, 2017, when Apotex filed the public version of a motion record that had been filed confidentially. The same information was repeatedly communicated publicly in the context of the same motion, including in Prothonotary Mireille Tabib's April 3, 2017 decision. Neither Apotex nor Pharmachem gave any indication to the Court that the two words in question were considered confidential until February 16, 2018, upon issuance of 2018 FC 181. Despite the assertion that these two words are sensitive, and that their release to the public was in error and not noticed until preparation of of submissions in the context of the present request for redactions, the Court is not convinced. The Court notes the absence of any affidavit or declaration of any employee of Apotex or Pharmachem. Moreover, Apotex and Pharmachem have not made reference to any action taken or statement made before, during or since the trial of this matter in which they indicated, suggested or implied that the two words in question (aside from the manufacturing process more broadly) were considered confidential. The Court finds it more likely that Apotex and Pharmachem have simply changed their view as to the sensitivity of these two words. It is too late for such a change." placed on file on 12-MAR-2018 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 12-MAR-2018 directing that "The requested extension is granted." placed on file on 12-MAR-2018

Letter from Defendant dated 09-MAR-2018 re: Further to Mr. Justice's Locke's judgment dated Feb. 15, 2018... (Scanned to Locke, J.) received on 09-MAR-2018

Communication to the Court from the Registry dated 07-MAR-2018 re: Doc. 138 sent to the Court (Locke, J.) for his consideration

Affidavit of service of Erin Park sworn on 05-MAR-2018 on behalf of Plaintiff confirming service of 138 upon Defendant by courier on 05-MAR-2018 filed on 05-MAR-2018

Sealed envelope pursuant to Confidentiality Order dated 13-MAY-2015 on behalf of Apotex filed pursuant to Oral Directions from the Court dated 23-FEB-2018 Filed on 05-MAR-2018

Letter from Respondent dated 28-FEB-2018 re: Confidential Submissions as per Direction of the Court dated Feb. 23, 2018. (Scanned to Locke, J.) filed on 28-FEB-2018

Communication to the Court from the Registry dated 23-FEB-2018 re: Confidentiality submissions sent to the Court (Locke, J.)

Acknowledgment of Receipt received from Defendant with respect to Directions of the Court (Locke, J.) dated 23-FEB-2018 placed on file on 23-FEB-2018

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 23-FEB-2018 directing that "As requested, AstraZeneca may, no later than February 28, 2018, make submissions concerning Apotex's proposed redactions from the public version of 2018 FC 181. Apotex may, no later than March 5, 2018, make reply submissions." placed on file on 23-FEB-2018

Letter from the Plaintiff (Apotex Inc.) dated 22-FEB-2018 "...This correspondence responds to AstraZeneca's counsel's letter sent yesterday indicating AstraZeneca's position regarding confidentiality but requesting an amendment to the Court's Direction of February 16, 2018 by granting AstraZeneca an opportunity to respond to Apotex's submissions on confidentiality..." (Scanned to Locke, J.) received on 22-FEB-2018

Cases from Apotex Inc. et al Confidentiality Submissions consisting of 1 volume(s) on behalf of Plaintiff received on 22-FEB-2018

Affidavit of service of Nancy Borges sworn on 22-FEB-2018 on behalf of Plaintiff confirming service of confidentiality submissions (ID 394) upon Defendant by email on 22-FEB-2018 with Exhibits A filed on 22-FEB-2018

Sealed envelope pursuant to Order dated May 12, 2015 on behalf of Plaintiff purporting to contain Apotex Inc. and Apotex Pharmachem Inc.'s Confidentiality Submissions pursuant to oral directions dated 16-FEB-2018 Received on 22-FEB-2018

Letter from AstraZeneca Canada Inc. dated 21-FEB-2018 "We are counsel for AstraZeneca Canada Inc. in the above referenced proceedings. Kindly bring this letter to the attention of Mr. Justice Locke. We write further to Mr. Justice Locke's Direction of February 16, 2017 which advised that the parties may make submissions as to portions of the Judgment and Reasons in the Section 8 Action ("Judgment") that should be redacted from the public version of that decision no later than February 22, 2018. We write to advise the Court that AstraZeneca does not require any redactions to be made to the Judgment for the purpose of the issuance of a public version of the Judgment." received on 21-FEB-2018

Acknowledgement of receipt of direction dated 16-Feb-2018 by plaintiff and defendant by email this date. placed on file on 16-FEB-2018

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 16-FEB-2018 directing that In response to Apotex letter 16-Feb-2018, the Court directs: At Apotex's request,the decision in the Section 8 Action will not be made public for the time being.The parties may make submissions as to portions that should be redacted from the public version of that decision no later than February 22,2018. Parties advised. placed on file on 16-FEB-2018

Letter from Plaintiff dated 16-FEB-2018 We ask that this correspondence be brought to the attention of Mr.Justice Locke re:Judgment and Reasons yesterday. We would appreciate opportunity to make submissions re:confidentiality of Judgment/Reasons;request Judgment not be released at this time and a Direction to this effect. received on 16-FEB-2018

MEMORANDUM to CASE MANAGEMENT JUDGE, Tabib, P., from Cynthia Leaver, Ottawa Registry, enclosing a certified copy of the (Final) Judgment and Reasons of Locke, J., dated 15-FEB-2018. Sent by internal mail on 15-FEB-2018. placed on file on 15-FEB-2018

Acknowledgment of Receipt received from 2 counsel/parties by fax on 15-FEB-2018 with respect to the (Final) Judgment and Reasons doc. 135 of Locke, J., dated 15-FEB-2018. placed on file on 15-FEB-2018

Reasons CONFIDENTIAL JUDGMENT AND REASONS dated 15-FEB-2018 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: CONFIDENTIAL Filed on 15-FEB-2018 certified copies sent to 2 counsel/parties by fax on 15-FEB-2018 Transmittal Letters placed on file. Final Decision Certificate of CONFIDENTIAL JUDGMENT AND REASONS - J&O vol. 1360 pages 26-27 = CANCELLED entered in J. & O. Book, volume 1360 page(s) 26 - 27

Sealed envelope pursuant to Order 13-May-2015 on behalf of ASAP Reporter Services (Court Reporter) purporting to contain CONFIDENTIAL Transcript of hearing (volume 16) dated January 12,2018 before Locke J. -176 pages; and Condensed version of Transcript with Word Index (vol.16). Received on 26-JAN-2018

Sealed envelope pursuant to Order 13-May-2015 on behalf of ASAP Reporting Services (Court Reporter) purporting to contain CONFIDENTIAL Transcript (vol.15) of hearing January 11,2018 before Locke J. 160 pages; and Condensed Transcript (vol.15) with Word Index. Received on 26-JAN-2018

Communication to the Court from the Registry dated 16-JAN-2018 re: Letter 16-Jan-2018 scanned to Locke J.

Letter from Plaintiff dated 16-JAN-2018 Apotex correspondence follows parties attendance before the court last week...Counsel for AstraZeneca takes no position with respect to correspondence.Reference to decision Manson J. t-1064-13..the Court addressed pleading amendments sought by Apotex...to advise that Manson J. decision was under appeal and cross-appeal file A-334-17. received on 16-JAN-2018

Memorandum to file from Toronto dated 15-JAN-2018 Judges materials from hearing 11-Jan-2018 were forwarded to the Court as per the Court's direction. placed on file.

Sealed envelope pursuant to Order July 25,2011 on behalf of Defendant purporting to contain Astrazeneca's Second Supplemental Compendium Received on 11-JAN-2018

Plaintiff-Apotex Compendium received on 11-JAN-2018

Toronto 11-JAN-2018 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Continuation of the Trial in this action Result of Hearing: Matter reserved Before the Court: Oral motion Plaintiff motion to adjourn the hearing as premature. Result of Hearing: Direction: Hearing to proceed held in Court Senior Usher: Anne Bruchalski Duration per day: 11-JAN-2018 from 09:30 to 04:45 Courtroom : Courtroom No. 4-D - Toronto Court Registrar: Jim Outtrim Total Duration: 1d Appearances: Mr.H.B.Radomski 416-979-2211 representing Plaintiff Mr.Jerry Topolski 416-979-2211 representing Plaintiff Mr.Gunars Gaikis 416-593-5514 representing Defendant Ms.Yoon Kang 416-593-5514 representing Defendant Mr.Kevin P.Siu 416-593-5514 representing Defendant Court Reporter: Lisa Lamberti, ASAP Reporting Service,Toronto 416-861-8720 11-JAN-2018 Transcript not requested Comments: Matter reserved.Plaintiff submitted at hearing case law,Compendium;Defendant submitted at hearing Second Supplementary Compendium. ASAP Reporting to provide a complement copy of transcript of hearing to the Court. Please note that the parties request that the Minutes of hearing be CONFIDENTIAL. Transcript to indicate same. DARS Recording Z006205. Minutes of Hearing entered in Vol. 989 page(s) 54 - 66 Abstract of Hearing placed on file

Memorandum to file from Toronto dated 08-JAN-2018 The parties agree to reserve and split the court reporters fees for hearing January 11 and 12,2018. placed on file.

Oral directions received from the presiding judge dated 08-JAN-2018 directing that The parties shall be robed for continuation of trial on January 11,2018 but not for the motions on January 12,2018. Concerning the Court reporter I am happy to follow whatever the parties want. placed on file on 08-JAN-2018

Solicitor's certificate of service on behalf of Michael Yasskin (Plaintiff) confirming service of Doc 133 & ID 375 upon Defendant by personal service on 12-DEC-2017 filed on 12-DEC-2017

Book of Authorities consisting of 3 volume(s) on behalf of Plaintiff received on 12-DEC-2017

Responding Submissions of Apotex Inc. (Re: 653 Patent) - per direction of the Court (Locke J.) dated 10-OCT-2017 filed on 12-DEC-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 12-DEC-2017 directing that Apotex's responding submissions and book of authorities may be accepted for filing. placed on file on 12-DEC-2017

Envelope containing a USB key containing AstraZenecas Reply Submissions 1 copy held in Toronto filed on 11-DEC-2017

Solicitor's certificate of service on behalf of Andrew Mandlsohn confirming service of Doc 130 and a book of authorities and a USB key upon Plaintiff by personal service on 11-DEC-2017 filed on 11-DEC-2017

Astrazeneca's book of authorities consisting of 1 volume(s) on behalf of Defendant received on 11-DEC-2017

Confidential Reply Submissions (Purusant to 10-OCT-2017 oral direction) on behalf of Defendant Filed on 11-DEC-2017

Solicitor's certificate of service on behalf of Andrew E. Mandlsohn confirming service of ID#367 upon Plaintiff by personal service on 21-NOV-2017 filed on 21-NOV-2017

Sealed envelope pursuant to order dated May 12/2015 on behalf of Defendant purporting to contain Astrazeneca Supplemental Compendium (3 copies) Received on 21-NOV-2017

Solicitor's certificate of service on behalf of Sandon Shogilev (Plaintiff) confirming service of Doc 127 upon Defendant by personal service on 20-NOV-2017 filed on 20-NOV-2017

CLOSING SUBMISSIONS OF APOTEX INC. (re: '653 Patent) on behalf of Plaintiff (3 copies + PDF scanned to Locke J.) filed on 20-NOV-2017

Solicitor's certificate of service on behalf of Andew E. Mandlsohn confirming service of Docs. 124, 125 and IDs 362, 363 upon Plaintiff by personal service on 20-NOV-2017 filed on 20-NOV-2017

Sealed envelope pursuant to Order dated 12-MAY-2015 on behalf of Defendant purporting to contain 1 USB Key containing Docs. 124, 125 and Supplemental Book of Authorities Received on 20-NOV-2017

Supplemental Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 20-NOV-2017

Supplementary Trial Record on behalf of Defendant filed on 20-NOV-2017

Sealed envelope pursuant to Confidential Order dated 12-MAY-2015 on behalf of Defendant purporting to contain Astrazeneca's Supplemental Written Submissions pursuant to the Directions of Justice Locke dated 10-OCT-2017 Filed on 20-NOV-2017

****** CANCELLED ****** Oral directions received from the Court: The Honourable Mr. Justice Locke dated 25-OCT-2017 directing that "A trial management conference shall be held on Tuesday, October 31st, 2017, at 9:30 a.m." placed on file on 25-OCT-2017

Letter from Apotex dated 24-OCT-2017 responding to AstraZeneca's letter dated October 24th, 2017. Scanned to Justice Locke. received on 24-OCT-2017

Letter from AstraZeneca dated 24-OCT-2017 advising that the Supreme Court of Canada dismissed Apotex's motion for amendment of the judgment dated June 30th, 2017. Counsel request that the Court issue a direction for the parties to jointly submit a schedule for the next steps in T-1668-10. Scanned to Justice Locke. received on 24-OCT-2017

Affidavit of service of Jessica Oliveira sworn on 16-OCT-2017 on behalf of Plaintiff confirming service of doc 122 upon Defendant by telecopier on 16-OCT-2017 filed on 16-OCT-2017

Amended (THIRD) REPLY of APOTEX INC. filed on 16-OCT-2017

Acknowledgment of Receipt received from all parties with respect to Direction of the Court ID 353 placed on file on 10-OCT-2017

Written directions received from the Court: The Honourable Mr. Justice Locke dated 10-OCT-2017 directing that "Further to the trial management conference this day concerning arrangements for the Court to hear supplemental submissions in light of the Supreme Court of Canada's decision on June 30, 2017 (2017 SCC 36), the following schedule shall be respected: 1. Service and filing of the parties' respective supplemental written submissions (of no more than 20 pages) in lenght, and including an electrinic version): no later than November 20. 2017 2. Service and filing of the parties¿ respective responding submissions (of no more than 8 pages in length, and including an electronic version): no later than December 11, 2017 3. One-day hearing in Toronto: January 11, 2018 Regardless of the content of the pleadings as amended, and regardless of the disposition of Apotex¿s pending motion before the Supreme Court of Canada, this Court will not make any determination of the validity of the 653 Patent in the context of the submissions and hearing contemplated above. Any such issue that remains in dispute after the disposition of Apotex¿s motion may be addressed in a separate hearing." placed on file on 10-OCT-2017 Confirmed in writing to the party(ies)

Ottawa 10-OCT-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: A direction containing a timetable for filing and service of the supple- mental written submissions and a hearing date will be issued. held in chambers by way of Conference Call Duration per day: 10-OCT-2017 from 10:00 to 11:02 Courtroom : Judge's Chambers - Ottawa Court Registrar: Laurence Bélanger Total Duration: 1h Appearances: Mr. Jerry Topolski 416-597-4142 representing Plaintiff Mr. Harry Radomski 416-597-4142 representing Plaintiff Mr. Kevin Siu 416-595-2755 representing Defendant Mr. Gunars Gaikis 416-595-2755 representing Defendant Mr. Andrew Mandlsohn 416-595-2755 representing Defendant Comments: backup recorder was used Minutes of Hearing entered in Vol. 982 page(s) 98 - 104 Abstract of Hearing placed on file

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 05-OCT-2017 directing that "A trial management conference shall be held on Tuesday, October 10th, 2017, for no later than one hour beginning at 10:00 a.m. The TMC will be held via teleconference. Counsel for the parties may remain in their respective in their respective offices." placed on file on 05-OCT-2017

Letter from Apotex dated 04-OCT-2017 in response to AstraZeneca's letter dated October 3, 2017. Scanedd to Justice Locke. received on 04-OCT-2017

Letter from the defendant AstraZeneca dated 03-OCT-2017 in response to Apotex's letter dated September 29, 2017. Scanned to Justice Locke. received on 03-OCT-2017

Copy of Invoice for (ARV#1630) for payment of Court fees for the amount of $1875.00 (original on T-1668-10) hearings over three days received from Smart & Biggar on September 28, 2017

Letter from Plaintiff dated 29-SEP-2017 in response to the courts direction dated September 25th, 2017. Scanned to Justice Locke. received on 29-SEP-2017

Covering letter from Defendant dated 29-SEP-2017 concerning Doc. Nos. 120 121 placed on file on 29-SEP-2017

Affidavit of service of KINGSLEY W. KOO sworn on 29-SEP-2017 on behalf of Defendant confirming service of DOC 120 upon Plaintiff by telecopier on 29-SEP-2017 filed on 29-SEP-2017

THIRD AMENDED STATEMENT OF DEFENCE OF ASTRAZENECA CANADA INC filed on 29-SEP-2017

Acknowledgment of Receipt received from 2 counsel for the parties by fax letter on 25-SEP-2017 with respect to Oral Directions ID 342 of Locke, J. dated 25-SEP-2017 placed on file on 25-SEP-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 25-SEP-2017 directing that "Following review of the most recent letters received on behalf of the parties, the Court directs as follows: 1. No later than September 29, 2017, Apotex shall a. From the list of dates offered in the Court's Direction dated September 23, 2017, indicate only those on which Apotex is not available for a one-day hearing; b. Indicate the nature of the additional evidence that it believes may be necessary to address issues that it expects will be raised in pleading amendments; c. Indicate its reaction to AstraZeneca's proposed page limit of 20 pages for supplemental written submissions. 2. No later than October 10, 2017 (or any later date agreed to by Apotex), AstraZeneca shall serve and file its amended defence in T-389-11. 3. No later than 15 days following service of AstraZeneca's amended defence in T-389-11 (or any later date agreed to by AstraZeneca), Apotex shall serve and file its amended reply in T-389-11. At that time, and provided it has discussed the issues with AstraZeneca, Apotex may propose dates for a case management conference to address: a. The possibility that additional evidence may be necessary; b. The possibility of avoiding viva voce evidence in the event the additional evidence is necessary; c. The page limit for supplemental written submissions. 4. At least three days prior to any such case management conference, the parties shall, preferably jointly, report to the Court concerning their discussions on the issues to be addressed. 5. The timetable for the exchange of supplemental written submissions and the date of the hearing of oral submissions shall be determined at a later date." Sent by Registry by fax letter to 2 counsel for parties on 25-SEP-2017. placed on file on 25-SEP-2017 Confirmed in writing to the party(ies)

Letter from Defendant dated 22-SEP-2017 in response to the Courts direction dated September 13, 2017 and the Plaintiffs letter dated September 21, 2017. Scanned to Justice Locke. received on 22-SEP-2017

Letter from Plaintiff dated 21-SEP-2017 requesting a case management conference with Justice Locke, Trial Judge further to direction of September 13th, 2017. Scanned to Justice Locke. received on 21-SEP-2017

Responding Motion Record that was filed in the Supreme Court of Canada on behalf of Astrazeneca Canada Inc. et Al. Documentation was submitted via e-mail on September 13, 2017. -Scanned to Justice Locke- received on 13-SEP-2017

Acknowledgment of Receipt received from all parties with respect to the direction dated September 13th, 2017 placed on file on 19-SEP-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 13-SEP-2017 directing that "Having considered the parties' representations during the recent trial management conference, the Court has concluded that, regardless of the Supreme Court's dispositionnof Apotex's motion before that Court, the validy of Canadian Patent No 2,139,653 will not be impeached in the near future. Therefore, it is appropriate to make arrangements now for receiving the parties' further submissions in the trial that was heard in May and June of this year, based on the situation as it currently stands. The Court expects that a timetable will have to be set for the following steps: 1. Service and filing of an amended defence. 2. Service and filing of an amended reply. 3. Service and filing of the parties' supplemental written submissions 4. One-day hearing in Toronto. The Court wishes to set a date for the hearing first, and then determine the other deadlines thereafter. Accordingly, the parties are directed to provide, no later than September 22 , 2017, their availability for a one-day hearing during any of the following periods: November 6-10, November 20-23, December 18-22, January 8-12, or March 5-13. At the same time, the parties may, after consulting one another , propose a page limit for their supplemental written submissions." placed on file on 13-SEP-2017 Confirmed in writing to the party(ies)

Certified French language Translation of ORDER AND REASONS rendered on 02-JUN-2017 by The Honourable Mr. Justice Locke filed on 13-SEP-2017 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for ORDER AND REASONS entered in J. & O. Book, volume 1345 page(s) 221 - 229

Montréal 06-SEP-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: The Court (Mr Justice Locke) will take the comments from and discussion held with Counsel for both parties, under reserve and will convene Counsel for a further Case or Trial Management Conference, in due time, if necessary. held by way of Conference Call Senior Usher: Gaetan Roy Duration per day: 06-SEP-2017 from 11:00 to 11:50 Courtroom : Teleconference Room 341 - Montréal Court Registrar: Sonya Brault Total Duration: 50min Appearances: Mr Harry Radomski 416-597-4142 representing the Plaintiff: APOTEX INC. Mr Jerry Topolsky 416-597-4142 representing the Plaintiff: APOTEX INC. Mr Gunars Gaikis 416-595-2755 representing the Defendant: ASTRAZENECA CANADA INC. Ms Yoon Kang 416-595-2755 representing the Defendant: ASTRAZENECA CANADA INC. Mr Kevin Siu 416-595-2755 representing the Defendant: ASTRAZENECA CANADA INC. Mr Andrew Mandlsohn 416-595-2755 representing the Defendant: ASTRAZENECA CANADA INC. Comments: Following the instructions of the Court, this Trial Management Conference was not recorded using the SEAN/DARS or TASCAM audio recording units. Minutes of Hearing entered in Vol. 980 page(s) 268 - 271 Abstract of Hearing placed on file

Motion documents that were filed in the Supreme Court of Canada on Thursday August 31st, 2017. Submitted pursuant to the Oral Direction ID.333. Documents submitted on behalf of the Plaintiff on September 5th, 2017 and placed on file T-389-11 only. -scanned to Justice Locke- received on 05-SEP-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 05-SEP-2017 directing that "By no later than 4:30 on Tuesday, September 5, 2017, Apotex must submit to the Court and to AstraZeneca (if not already done) the motion documents that were filed in the Supreme Court of Canada last Thursday. The motion documents are to be submitted electronically." placed on file on 05-SEP-2017 Confirmed in writing to the party(ies)

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 02-AUG-2017 directing that The Trial Management Conference held today by teleconference is adjourned until Wednesday, September 6, 2017, at 11:00 a.m. The continuation of the TMC is to be held by teleconference and the parties may remain in their respective offices. placed on file on 02-AUG-2017 Confirmed in writing to the party(ies)

Montréal 02-AUG-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Case Management Conference Result of Hearing: Case management is adjourned to the later date to be determined by the Court held in Court by way of Conference Call Duration per day: 02-AUG-2017 from 09:05 to 09:40 Courtroom : Teleconference Room 341 - Montréal Court Registrar: Maxim Didkovski Total Duration: 35min Appearances: Mr Harry Radomsky, Mr Jerry Topolsky 416 597 4142 representing Plaintiff Mr Gunnars Gaikis, Ms. Yoon Kang, Mr. Andrew Mandlsohn, Mr. Kevin Siu 416 597 2755 representing Respondent Comments: File was heard together with T-1668-10, minutes were held in T-1668-10 only. Minutes of Hearing entered in Vol. 979 page(s) 175 - 176 Abstract of Hearing placed on file

Letter from Plaintiff (Apotex) dated 31-JUL-2017 "(...)The within correspondence responds to the letter from counsel for AstraZeneca dated July 27, 2017 and the Court's Direction of July 12, 2017 which sought the parties' position on steps to be taken, if any, in each of the above referenced proceedings.(...)" (scanned to Locke, J.) received on 31-JUL-2017

Letter from Defendant (AstraZeneca) dated 26-JUL-2017 "(...)This follows the Courts' Direction of July 12, 2017 requesting the AstraZeneca parties to submit to the Court their proposal for the next steps in the two actions in advance of the case management teleconference scheduled for August 2, 2017.(...)" (scanned to Locke, J.) received on 26-JUL-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 12-JUL-2017 directing that The Court would like to convene a case management conference on August 2, 2017, by teleconference at 11h00 am for one hour. "1. The Astrazeneca parties should submit to the Court, by no later than Thursday, July 27, 2017, their proposal for next steps in the two actions; and 2. The Apotex parties should indicate, by no later than Monday July 31, 2017, their position with regards to next steps and the Astrazeneca parties' proposal thereon." placed on file on 12-JUL-2017

Letter from Astrazeneca Canad Inc. dated 12-JUL-2017 re: In response to the Direction of the Court issued July 4,2017. (Scanned to Locke, J.) received on 12-JUL-2017

Acknowledgment of Receipt received from all parties with respect to the Direction of the Court issued on July 4, 2017. (via email) placed on file on 05-JUL-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 04-JUL-2017 directing that "This follows the decision of the Supreme Court of Canada (SSC) on June 30, 2017 in Astrazeneca Canada Inc. v. Apotex Inc. 2017 SCC 36 reversing an earlier finding that Canadian Patent No. 2,139,653 is invalid. In light of discussions that took place during trial in the present matters concerning the possible consequences of the SCC's decision, the parties are directed (after consulting with one another) to submit to the Court, by Thursday, July 13, 2017, a proposal for next steps in the present matters. If the parties feel it would be useful, they may propose a conference call with the Court." placed on file on 04-JUL-2017

Transcript of hearing held at Toronto on 15-JUN-2017 received on 20-JUN-2017 Sent directly to presiding Judge 205 pages (including covering pages).

Transcript of hearing held at Toronto on 14-JUN-2017 received on 20-JUN-2017 Sent directly to presiding Judge 197 pages (including covering pages).

Toronto 08-MAY-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial in this action Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 111 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Doug Duff 08-MAY-2017 Doug Duff 09-MAY-2017 Doug Duff 11-MAY-2017 Frank Kurina 15-MAY-2017 Frank Kurina 16-MAY-2017 Frank Kurina 17-MAY-2017 Frank Kurina 18-MAY-2017 Lisa Tirado 23-MAY-2017 Lisa Tirado 24-MAY-2017 Lisa Tirado 25-MAY-2017 John Grise 30-MAY-2017 John Grise 31-MAY-2017 John Doherty 14-JUN-2017 John Doherty 15-JUN-2017 Duration per day: 08-MAY-2017 from 09:30 to 16:53 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 09-MAY-2017 from 09:30 to 11:32 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 11-MAY-2017 from 09:30 to 15:05 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 15-MAY-2017 from 09:30 to 16:40 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 16-MAY-2017 from 09:30 to 15:45 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 17-MAY-2017 from 09:30 to 16:38 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 18-MAY-2017 from 09:30 to 16:27 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 23-MAY-2017 from 09:30 to 16:58 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 24-MAY-2017 from 09:30 to 16:42 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 25-MAY-2017 from 09:30 to 16:37 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 30-MAY-2017 from 09:30 to 16:45 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 31-MAY-2017 from 10:45 to 17:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 14-JUN-2017 from 09:30 to 16:52 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil 15-JUN-2017 from 09:00 to 17:15 Courtroom : Courtroom No. 5-D - Toronto Court Registrar: Alice Prodan Gil Total Duration: 14days Appearances: Harry Radomski 416-597-5907 representing Plaintiff Jerry Topolski 416-597-5907 representing Plaintiff Sandon Shogilev 416-597-5907 representing Plaintiff Michael Yasskin 416-597-5907 representing Plaintiff Gunars Gaikis 416-593-5514 representing Defendant Yoon Kang 416-593-5514 representing Defendant Andrew Mandlsohn 416-593-5514 representing Defendant Kevin Siu 416-593-5514 representing Defendant Abigail Smith 416-593-5514 representing Defendant Exhibits filed at hearing: P-1 to D-83 Witness(es) on behalf of Plaintiff Gordon Fahner 1209 Signet Drive, Weston, ON, M9L 1T9 on behalf of Plaintiff Dr. Alan Parr 1209 Kenbridge Lane, Carey, NC, 27511 on behalf of Plaintiff Mr. Howard Rosen 79 Wellington St. W., Ste 2010, Toronto, ON, M5K 1G8 on behalf of Plaintiff Dr. Martin Ehlert 150 Signet Drive, Toronto, ON, M9L 1T9 on behalf of Plaintiff Dr. Chetan Doshi 150 Signet Drive, Toronto, ON, M9L 1T9 on behalf of Plaintiff Dr. Stephen Horne 34 Spalding Drive, Brantford, ON, N3T 6B8 on behalf of Plaintiff Bernard Sherman 150 Signet Drive, Weston, ON, M9L 1T9 on behalf of Plaintiff Dr. Aidan Hollis 2500 University Drive, Calgary, AB, T2N 1N4 on behalf of Plaintiff Dr. David Burdick 6 Hawthorn Circle, Albany, NY, 12203 on behalf of Plaintiff Rosemary Bacovsky 3820 1st Street SW, Calgary, AB, T2S 1R3 on behalf of Plaintiff Susanne Picard 1235 3rd Avenue Val D'or, QC, J9P 6C3 Court Reporter: ASAP Court Reporting Services 416-861-8720 08-MAY-2017 Lisa Barrett 416-861-8720 09-MAY-2017 Lisa Barrett 416-861-8720 11-MAY-2017 Lisa Barrett 416-861-8720 15-MAY-2017 Lisa Barrett 416-861-8720 16-MAY-2017 Lisa Barrett 416-861-8720 17-MAY-2017 Lisa Barrett 416-861-8720 18-MAY-2017 Lisa Barrett 416-861-8720 23-MAY-2017 Lisa Barrett 416-861-8720 24-MAY-2017 Lis

Sealed envelope pursuant to Protective Order dated 12-MAY-2017 on behalf of Defendant purporting to contain AstraZeneca's Compendium (Re: Closing Argument) 7 volumes Received on 14-JUN-2017

Sealed envelope pursuant to Protective Order dated 12-MAY-2017 on behalf of Plaintiff purporting to contain Compendium of Apotex Inc. (Volumes I, II, III) Received on 14-JUN-2017

Sealed envelope pursuant to Protective Order dated 12-MAY-2017 on behalf of Plaintiff purporting to contain Apotex's Compendium of Evidentiary Cites (7 volumes) Received on 14-JUN-2017

Book of Authorities consisting of 3 volume(s) on behalf of Defendant received on 08-JUN-2017

Book of Authorities consisting of 3 volume(s) on behalf of Plaintiff received on 08-JUN-2017

Sealed envelope pursuant to Protective Order dated 12-MAY-2015 on behalf of Defendant purporting to contain AstraZeneca's Written Closing Arguments Filed on 08-JUN-2017

Sealed envelope pursuant to Protective Order dated 12-MAY-2015 on behalf of Plaintiff purporting to contain Closing Argument of Apotex Inc. Filed on 08-JUN-2017

Transcript of hearing held at Toronto on 31-MAY-2017 received on 05-JUN-2017 Sent directly to presiding Judge 202 pages (including covering pages).

Transcript of hearing held at Toronto on 30-MAY-2017 received on 02-JUN-2017 Sent directly to presiding Judge 207 pages (including covering pages).

Acknowledgment of Receipt received from Mr. Siu (by email) with respect to Order and Reasons from the Court (Locke, J.) dated June 2, 2017. placed on file on 02-JUN-2017

Reasons (Order and Reasons) dated 02-JUN-2017 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial of the matter Result: "THIS COURT ORDERS that the parties' respective requests to order qualifying read-ins and to exclude read-ins are refused." Filed on 02-JUN-2017 Interlocutory Decision Copy of Reasons for (Order and Reasons) entered in J. & O. Book, volume 1336 page(s) 162 - 169

Revised Transcript of hearing held at Toronto on 18-MAY-2017 Sent directly to presiding judge 181 pages received on 01-JUN-2017

Transcript of hearing held at Toronto on 25-MAY-2017 received on 31-MAY-2017 Sent directly to presiding Judge 199 pages (including covering pages).

Revised Transcript of hearing held at Toronto on 23-MAY-2017 30-MAY-2017 sent directly to presiding judge 222 pages received on 30-MAY-2017

Transcript of hearing held at Toronto on 24-MAY-2017 received on 29-MAY-2017 Sent directly to presiding Judge 175 pages (including covering pages).

Transcript of hearing held at Toronto on 23-MAY-2017 received on 26-MAY-2017 Sent directly to presiding Judge 222 pages (including covering pages).

Transcript of hearing held at Toronto on 18-MAY-2017 received on 24-MAY-2017 Sent directly to presiding Judge 181 pages (including covering pages).

Transcript of hearing held at Toronto on 17-MAY-2017 received on 23-MAY-2017 Sent directly to presiding Judge 174 pages (including covering pages).

Transcript of hearing held at Toronto on 16-MAY-2017 received on 19-MAY-2017 Sent directly to presiding Judge 152 pages (including covering pages).

Solicitor's certificate of service on behalf of Kevin P. Siu confirming service of doc 114, Book of authorities upon Plaintiff by personal service on 18-MAY-2017 filed on 18-MAY-2017

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 18-MAY-2017

Motion Record containing the following original document(s): 111 112 113 Number of copies received: 3 on behalf of Defendant filed on 18-MAY-2017

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 111 filed on 18-MAY-2017

Affidavit of Kingsley W. Koo sworn on 18-MAY-2017 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 111 with Exhibits A-D filed on 18-MAY-2017

Notice of Motion contained within a Motion Record on behalf of Defendant returnable (but no hearing date indicated at this time) for an Order that the presentation of the final written and oral arguments for the actions T-1668-10 and T-389-11 be stayed until a decision is rendered by the SCC; an order or direction to stay the issuance of a trial decision pending the issuance of decision by SCC; and other relief filed on 18-MAY-2017

Transcript of hearing held at Toronto on 15-MAY-2017 received on 18-MAY-2017 Sent directly to presiding Judge 202 pages (including covering pages).

Transcript of hearing held at Toronto on 11-MAY-2017 received on 15-MAY-2017 Sent directly to presiding Judge 179 pages (including covering pages).

Transcript of hearing held at Toronto on 09-MAY-2017 received on 12-MAY-2017 Sent directly to presiding Judge 59 pages (including covering pages).

Transcript of hearing held at Toronto on 08-MAY-2017 received on 11-MAY-2017 Sent directly to presiding Judge 187 pages (including covering pages).

Letter sent by Registry on 11-MAY-2017 to Plaintiff regarding MP3 request Copy placed on file.

Request for copy of recording received from Michael Yasskin, counsel for the Plaintiff (Apotex), for the hearing held in Toronto on 21-NOV-2017 (request as Urgent) received on 11-MAY-2017

CONFIDENTIAL - Outline of Astrazeneca's Opening Submissions on behalf of the Defendant(handed directly to presiding judge) received at hearing on 08-MAY-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 08-MAY-2017 directing that for the duration of the trial, the parties may file documents on T-389-11 only placed on file on 08-MAY-2017

Proceedings Commenced by Astrazeneca Canada Against Apotex Inc. under the PM(NOC) Regulations (handed directly to presiding judge) received at hearing on 08-MAY-2017

Brief of Documents for Opening Argument on behalf of Plaintiff (handed to presiding judge) received at hearing on 08-MAY-2017

Letter from Plaintiff dated 24-APR-2017 attaching the trial schedule (sent to the trial judge and RO by e-mail on 25-Apr-2017) received on 24-APR-2017

Covering letter from Plaintiff dated 24-APR-2017 concerning Doc. No. 110 placed on file on 24-APR-2017

Joint list of issues to be determined at trial (sent to the trial judge and RO) filed on 24-APR-2017

Affidavit of service of Tanya Cabral sworn on 18-APR-2017 on behalf of Plaintiff confirming service of doc. 108 upon Defendant by courier on 17-APR-2017 filed on 18-APR-2017

Trial Record on behalf of Plaintiff filed on 18-APR-2017

Expert Reports of Apotex Inc. (Plaintiff) - 1 USB key provided and forwarded directly to Locke J. + 1 bound book containing Apotex's Expert Reports (body of report only) - 1 copy rec'd and forwarded directly to Locke J. filed on 18-APR-2017

Writ of Subpoena Ad Testificandum issued on 13-APR-2017 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 13-APR-2017 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 11-APR-2017 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 11-APR-2017 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 11-APR-2017 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 11-APR-2017 Tariff any other proceeding - $30.00

Writ of Subpoena Ad Testificandum issued on 11-APR-2017 cc filed

Request for Writ(s) of Subpoena Ad Testificandum on behalf of Plaintiff filed on 11-APR-2017 Tariff any other proceeding - $30.00

Acknowledgment of Receipt received from both parties with respect to the Order of the Court dated 3-Apr-2017 placed on file on 03-APR-2017

Order dated 03-APR-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 85 Result: dismissed Filed on 03-APR-2017 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1330 page(s) 357 - 363 Interlocutory Decision

Ottawa 29-MAR-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 85 on behalf of Plaintiff Result of Hearing: Matter reserved held in Court Senior Usher: Pierre Gendron Duration per day: 29-MAR-2017 from 09:31 to 14:04 Courtroom : Conference Room 1104, 11th Floor - Thomas D'Arcy McGee Bldg. - Ottawa Court Registrar: Marc Medas Total Duration: 4h 33mins Appearances: Mr. Sandon Shogilev and Mr. Michael Yasskin (416)849-6891 representing Plaintiff Mr. Gunars Gaikis and Mr. Kevin Siu (416)593-5514 representing Defendant Minutes of Hearing entered in Vol. 972 page(s) 154 - 159 Abstract of Hearing placed on file

Affidavit of service of Kevin P. Siu sworn on 24-MAR-2017 on behalf of Defendant confirming service of Docs. 94, 96 and the Book of Authorities of Astrazeneca Canada Inc. upon Plaintiff by personal service on 24-MAR-2017 filed on 24-MAR-2017

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 24-MAR-2017

PUBLIC VERSION Responding Motion Record of Astrazeneca Canada Inc. (Doc. 94) filed on 24-MAR-2017

****** CANCELLED ****** Motion Record in response to Motion Doc. No. 85 Number of copies received: 3 on behalf of Defendant filed on 24-MAR-2017

Sealed envelope pursuant to the Court ORder dated May 12, 2015 on behalf of Defendant purporting to contain CONFIDENTIAL Motion Record Filed on 24-MAR-2017

Written Representations (CONFIDENTIAL) contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 85 filed on 24-MAR-2017

Affidavit of CONFIDENTIAL sworn on 24-MAR-2017 contained within a Motion Record on behalf of Defendant in opposition to Motion Doc. No. 85 with Exhibits A-Q filed on 24-MAR-2017

Communication to the Court from the Registry dated 24-MAR-2017 re: Motion Doc. No. 85 sent to Court in advance of the motion being heard at General Sittings on Wednesday March 29th, 2017.

Acknowledgment of Receipt received from 2 counsel for the parties by fax on 24-MAR-2017 with respect to Order doc. 91 of Locke, J. dated 24-MAR-2017. placed on file on 24-MAR-2017

MEMORANDUM to CASE MANAGEMENT JUDGE, Tabib, P., from Cynthia Leaver, Ottawa Registry, enclosing a certified copy of Order doc. 91 (T-389-11) of Locke, J., dated 24-MAR-2017. Sent by internal mail on 24-MAR-2017. placed on file on 24-MAR-2017

Order dated 24-MAR-2017 rendered by The Honourable Mr. Justice Locke Matter considered with personal appearance The Court's decision is with regard to Trial Management Conference Result: "THIS COURT ORDERS that: 1. This Order shall govern the remaining steps to be taken in preparation for the trials; 2. Requests to admit and proposed iscovery read-ins shall be exchanged by the parties by April 7, 2017; 3. Updated witness lists shall be exchanged by the parties by April 17, 2017; 4. Will-say statements shall be exchanged by the parties by April 17, 2017; 5. Proposed expert qualifications shall be exchanged by the parties by April 17, 2017; 6. The parties shall deliver expert reports to the trial judge, as searchable PDF documents, by April 17, 2017; 7. The parties shall submit trial records to the trial judge, as searchable PDF documents, by April 17, 2017; 8. The parties shall notify each other of any demonstrative evidence they intend to rely upon at trial by April 24, 2017; 9. The parties shall submit a joint trial calendar by April 24, 2017; 10. The parties shall submit a joint issues list by April 24, 2017; 11. Responses to requests to admit and proposed responsive discovery read-ins shall be exchanged by April 28, 2017; 12. Objections to expert reports and qualifications shall be exchanged by April 28, 2017; 13. The parties shall notify each other of any objections to proposed demonstrative evidence by May 1, 2017." Filed on 24-MAR-2017 certified copies sent to 2 counsel for the parties by fax on 24-MAR-2017 Transmittal Letters placed on file. entered in J. & O. Book, volume 1330 page(s) 46 - 48 Interlocutory Decision

Communication to the Court from the Registry dated 23-MAR-2017 re: Forwarding letter dated March 23, 2017 to Court.

Letter from Plaintiff dated 23-MAR-2017 on consent of AstraZeneca, enclosing a draft scheduling order for further steps to be taken in preparation for the trials. In addition...we note that par. 9 of Case Management Judge Tabib's Order of Nov. 10, 2016 expressly provides that the trials be heard 4 days per week. The parties recognize that Justice Locke's views and availability will ultimately govern the sitting days for trial but we wanted to brign the earlier Order to the Court's attention as it may need to be amended. received on 23-MAR-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 22-MAR-2017 directing that "Following the trial management conference on March 13, 2017, the parties are directed to jointly file, no later than March 27, 2017, a draft scheduling order of steps leading to the commencement of the trial based on the proposed timetable set out in Apotex's counsel's letter dated March 10, 2017, as varied in discussion during the trial management conference. Also, further to the parties' request during the trial management conference, the Court agrees to adjourn early on Thursday, May 11 (around 3pm) to permit counsel to attend the CBA Federal Court Judges' Dinner in Ottawa." placed on file on 22-MAR-2017

Correction to General Sitting concerning Motion Doc. No. 85 Hearing added to General Sitting at Ottawa on 29-MAR-2017 at 09:30 duration: 1h Language: E Reason for correction: Direction of 28-Feb-2017

Affidavit of service of Lindsay Signorotti sworn on 10-MAR-2017 on behalf of Plaintiff confirming service of Public and confidential motion record and book of authorities upon Respondent by courier on 10-MAR-2017 filed on 10-MAR-2017

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 10-MAR-2017

Sealed envelope pursuant to the order of this court dated May 12,2015 on behalf of Plaintiff purporting to contain motion record of Apotex Inc to strike AstraZeneca Expert Report (Doc#88) Filed on 10-MAR-2017

Motion Record containing the following original document(s): 85 86 87 Number of copies received: 3 on behalf of Plaintiff (Public Version) filed on 10-MAR-2017

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 85 filed on 10-MAR-2017

Affidavit of Nicole Roth sworn on 10-MAR-2017 contained within a Motion Record on behalf of Plaintiff in support of Motion Doc. No. 85 with Exhibits A-I filed on 10-MAR-2017

Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at General Sitting in Ottawa on 29-MAR-2017 to begin at 09:30 duration: 1h language: E for an Order striking out the entire expert report of Dr. William A. Nugent ....and other such relief; filed on 10-MAR-2017

Sealed envelope pursuant to Direction dated February 24, 2017 on behalf of Plaintiff purporting to contain the Expert Report of Dr. Nugent(without exhibits) Filed on 27-FEB-2017

Montréal 13-MAR-2017 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: Order to follow held by way of Conference Call Duration per day: 13-MAR-2017 from 10:30 to 11:45 Courtroom : Teleconference Room 341 - Montréal Court Registrar: Marie-Eve Laroche Total Duration: 1h15m Appearances: S. Shogilev/M. Yasskin 416-849-6891 representing Apotex Inc. G. Gaikis/A. Mandlsohn/Y. Kang/K. Siu 416-593-5514 representing AstraZeneca Comments: Parties have to submit a joint draft scheduling order Minutes of Hearing entered in Vol. 971 page(s) 152 - 153 Abstract of Hearing placed on file

Letter from Plaintiff dated 10-MAR-2017 providing a proposed agenda for the TMC scheduled 13-Mar-2017. (sent to Justice Locke by e-mail on 10-Mar-2017) received on 10-MAR-2017

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 8-Mar-2017 placed on file on 09-MAR-2017

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 08-MAR-2017 directing that a trial management telephone conference will be held on Monday, March 13, 2017 at 10:30 am. Though the parties may propose additional items for the agenda due March 10, 2017, I wish to include at least the following items: 1. Contingencies sorrounding the pending decision of the Supreme Court of Canada in Case No. 36654. 2. Date of filing of expert reports. 3. Joint list of issues in dispute placed on file on 08-MAR-2017 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 07-MAR-2017 further to the PTC held March 3, 2017 and the Direction dated March 6, 2017...Parties are mutually available to conduct a Trial Management Conference by telephone on.....In the alternative, parties are mutually available to conduct a TMC to be held in person in Toronto on the same dates. Apotex does not consent to the PTC memorandum being disclosed to the Trial Judge...parties confirm that the evidentiary evidence portion of the trial will take no more than 20 days. Finally, the parties propose the following scehdule for further steps to be taken in preparation for the trials: (see letter for details)-Scanned to CMJ/sent to Trial Judge received on 07-MAR-2017

Order dated 06-MAR-2017 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Pre-Trial Conference Result: 1. The parties shall, by March 7, 2017: a) provide their mutual dates and places of availability for a Trial Management Conference to be held, either in person in Montreal, Ottawa or Toronto, or by telephone; b)Provide a joint proposed schedule for the further steps to be taken in preparation for trial; c) Advise or confirm, as the case may be, whether they consent to both parties¿ Pre-Trial Conference memoranda being being disclosed to the trial judge for his preparation; d) Advise of confirm as the case may be, that the evidentiary portion of the trial will not take more than 20 days. 2. The parties shall, by March 10, 2017, file a proposed agenda for a Trial Management Conference. 3. Apotex shall endeavour to advise AstraZeneca, by March 10, 2017, if it expects that any of the Apotex employees identified in AstraZeneca¿s Pre-Trial Conference Memorandum might be unavailable during the trial. 4. The trial records shall contain: the most recent pleadings and particulars thereto, all operative bifurcation orders and any other document that the parties may jointly advise by March 10, 2017. Filed on 06-MAR-2017 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1328 page(s) 87 - 89 Interlocutory Decision

Ottawa 03-MAR-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Pre-Trial Conference Result of Hearing: An Order will issue to parties regarding deadlines discussed at the PTC held in chambers by way of Conference Call Duration per day: 03-MAR-2017 from 09:30 to 11:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 1.5h Appearances: Sandon Shogilev 416-849-6891 representing Apotex Inc. G. Gaikis/A. Mandlsohn/K. Siu 416-593-5514 representing AstraZeneca parties Comments: Hear together with T-1668-10 Minutes of Hearing entered in Vol. 970 page(s) 399 - 408 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 28-FEB-2017 directing that "The Case Management Judge will hear Apotex's motion to strike AstraZeneca's expert report at the General Sittings in Ottawa at 9:30a.m. on March 29, 2017. The moving motion record is to be served and filed by March 10, 2017. The responding motion record is to be served and filed by March 24, 2017. placed on file on 01-MAR-2017 Confirmed in writing to the party(ies)

Ottawa 28-FEB-2017 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the Plaintiff's letters dated February 17 and 21 concerning their intended motion to strike an expert report (Heard together with T-1668-10) Result of Hearing: See 'COMMENTS' below for Oral Direction held in chambers by way of Conference Call Duration per day: 28-FEB-2017 from 09:00 to 09:45 Courtroom : Judge's Chambers - Ottawa Court Registrar: Christen Clement Total Duration: 45min Appearances: Sandon Shogilev/Michael Yaskin 416-849-6891 representing Plaintiff Gunnars Gaikis/Kevin Siu 416-595-2755 representing Defendant Comments: Oral Direction: 'The Case Management Judge will hear the hear Apotex's motion to strike AstraZeneca's expert report at the General Sittings in Ottawa at 9:30a.m. on March 29, 2017. The moving motion record is to be served and filed by March 10, 2017. The responding motion record is to be served and filed by March 24, 2017.' Minutes of Hearing entered in Vol. 969 page(s) 342 - 346 Abstract of Hearing placed on file

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 24-FEB-2017 directing that "A case management telephone conference will be held at 9 am on February 28, 2017. Apotex is asked to provide, under seal, a copy of the expert report at issue without attachments. placed on file on 24-FEB-2017 Confirmed in writing to the party(ies)

Solicitor's certificate of service on behalf of Kevin P. Siu confirming service of Doc 81 upon Apotex Inc. by personal service on 24-FEB-2017 filed on 24-FEB-2017

Pre-trial conference memorandum on behalf of Defendant filed on 24-FEB-2017 in triplicate. 1 copy(ies) for the Court Sent directly to Presiding Judge.

Letter from Apotex Inc. dated 21-FEB-2017 further to the direction dated February 17, 2017, providing further grounds expected to be raised in the motion to strike and advising that the motion ought to be addressed by Case Management Judge Tabib... received on 21-FEB-2017

confirmation of receipt from all counsel of the Direction dated February 17, 2017 placed on file on 17-FEB-2017

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 17-FEB-2017 directing that "Apotex is asked to provide further details as to the grounds expected to be raised in the motion to strike, to assist the Court in determining whether the motion should preferably be heard by the trial judge or the case management judge." placed on file on 17-FEB-2017 Confirmed in writing to the party(ies)

Letter from Plaintiff dated 17-FEB-2017 requesting a case management conference to schedule a motion to strike an expert report received on 17-FEB-2017

Affidavit of service of Tanya Cabral sworn on 10-FEB-2017 on behalf of Plaintiff confirming service of Doc 79 upon Defendant by courier on 10-FEB-2017 filed on 10-FEB-2017

Pre-trial conference memorandum on behalf of Plaintiff filed on 10-FEB-2017 in triplicate. 1 copy(ies) for the Court Sent directly to Presiding Judge.

Communication to the Court from the Registry dated 11-JAN-2017 re: scheduling the PTC

Notice of pre-trial conference dated 16-JAN-2017 further to the directions of Mireille Tabib, Prothonotary fixing Pre-Trial Conference to be heard at Special Sitting in Ottawa on 03-MAR-2017 to begin at 09:30 duration: 1h 30min language: E Filed on 16-JAN-2017 issued to parties ( to be heard by telephone conference)

Memorandum to file from Julie Dulac dated 12-DEC-2016 I received an e-mail from each party advising that they are generally available at the end of February beginning of March 2017 for a PTC. Apotex requests that it be scheduled at 4:45 or later. Both parties also advised that they do not have objections to Mr. Justice's law clerk being involved in the matter (communicated to the CMJ and the trial judge on 12-Dec-2016) placed on file.

Acknowledgment of Receipt received from both parties with respect to the Order of the Court dated 9-Dec-2016 placed on file on 09-DEC-2016

Order dated 09-DEC-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1. The bifurcation order dated April 7, 2011, as amended November 18, 2013, shall be further amended, nunc pro tunc, to add subparagraph 1d: d. All issues pertaining to Canadian Patent No. 2, 193, 994, including liability for infringement and invalidity. 2. The parties have leave to serve and rely on reports from up to six (6) experts in total between Court Files Nos. T-389-11 and T-1668-10, without prejudice to their right to seek leave to serve and reply on reports from additional experts. 3. The parties are to advise, no later than December 20, 2016, of the following matters: (a) The parties' mutual dates of availability to participate in a pre-trial conference, by telephone, at the end of February or early March 2017. (b) Whether they have any objections to the involvement of Patrick Levesque as Justice Locke's law clerk in this matter, due to his former employment with counsel for AstraZeneca. 4. Apotex's pre-trial conference memorandum will be served and filed no later than February 10, 2017. 5. AstraZeneca's pre-trial conference memorandum shall be served and filed no later than February 24, 2017. 6. A joint proposed schedule with respect to pre-trial deadlines and steps will be submitted as part of or alongside the parties' memoranda, including the deadline in April 2017 by which the parties will submit the joint trial calendar they agreed to prepare Filed on 09-DEC-2016 copies sent to parties entered in J. & O. Book, volume 1321 page(s) 243 - 245 Interlocutory Decision

Communication to the Court from the Registry dated 08-DEC-2016 re: the parties draft order submitted December 2, 2016

Draft Order concerning nunc pro tunc bifurcation and leave to rely on additional expert reports consented to by all parties received on 02-DEC-2016

Acknowledgment of Receipt received from all parties by email with respect to Docs.75 & 76 placed on file on 29-NOV-2016

Order dated 28-NOV-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 68 Result: granted in part Filed on 28-NOV-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1320 page(s) 84 - 87 Interlocutory Decision

Order dated 28-NOV-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 64 Result: granted in part Filed on 28-NOV-2016 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1320 page(s) 79 - 83 Interlocutory Decision

Toronto 21-NOV-2016 BEFORE The Honourable Mr. Justice Locke Language: E Before the Court: Trial Management Conference Result of Hearing: See Comments Before the Court: Case Management Conference Result of Hearing: See Comments held in Court Senior Usher: Anne Street Duration per day: 21-NOV-2016 from 10:40 to 11:30 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Taina Wong Total Duration: 50min Appearances: Harry Radomski, Jerry Topolski, and Michael Yasskin 416.979.2211 representing Plaintiff Gunars A. Gaikis, Kevin P. Siu, and Urszula Wojtyra 416.593.5514 representing Defendant Comments: Madam Prothonotary Tabib also presided over the hearing. A Joint Trial Calendar is to be submitted to the Court in April 2017. A Pre-Trial Conference will take place at the end of February 2017 before Madam Prothonotary Tabib. Apotex's pre-trial brief is due 10-FEB-2017, and AstraZeneca's pre-trial brief is due 24-FEB-2017. A Joint Proposed Schedule with respect to pre-trial deadlines/steps is to be submitted with the pre-trial briefs. The parties are to submit a draft Order on consent with respect to the following issues: nunc pro tunc bifurcation and leave to file additional expert reports. This draft Order is due by 2-DEC-2016. This TMC/CMC was heard with related file T-1668-10. A back-up recorder was used to record this hearing. Minutes of Hearing entered in Vol. 962 page(s) 192 - 195 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 21-NOV-2016 re: the parties' draft orders re: motions to compel doc,64 and 68

Draft Order concerning Motion Doc. No. 68 received on 21-NOV-2016

Draft Order concerning Motion Doc. No. 64 received on 21-NOV-2016

Letter from Apotex dated 10-NOV-2016 providing the parties' proposed agenda for the TMC/CMC scheduled on November 21, 2016 (sent to the Trial Judge and the CMJ by e-mail on 14-Nov- 2016) received on 10-NOV-2016

Acknowledgment of Receipt received from both parties with respect to the Order of the Court dated 10-Nov-2016 placed on file on 10-NOV-2016

Order dated 10-NOV-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Case Management Conference Result: 1This order shall supersede all prior Orders of the Court setting a schedule in these actions. 2. The parties shall submit draft Orders arising from their respective refusals motions by November 16, 2016. 3. A joint Case Management and Trial Management Conference is to take place on November 21, 2016 commencing at 10 am in Toronto. In this regard, the parties are to submit a joint pleadings brief and a proposed agenda by November 14, 2016. 4. Expert reports in chief (the Defendant in T-389-11 and Plaintiffs in T-1668-10 on infringement of the 994 Patent; the Plaintiff in T-389-11 and Defendants in T-1668-10 on section 8 and invalidity of the 994 Patent) shall be served by November 25, 2016. 5. Answers to all questions ordered answered and undertaken to be answered flowing from the second round motions to compel are to be delivered by December 2, 2016. 6. Responding expert reports shall be served by February 3, 2017. 7. The deadline for the delivery of productions by the parties without leave of the Court is February 3, 2017. 8. The parties shall serve and file any motion for leave to rely on reply expert reports by March 3, 2017. 9. The trial of these matters shall take place before this Court at 180 Queen Street West, in the City of Toronto, Ontario, commencing on the 8th day of May 2017, at 9:30 in the forenoon for a duration of thirty (30) days, such trial being heard four (4) days per week Filed on 10-NOV-2016 copies sent to parties entered in J. & O. Book, volume 1318 page(s) 309 - 311 Interlocutory Decision

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 9-Nov-2016 placed on file on 09-NOV-2016

Oral directions received from the Court: The Honourable Mr. Justice Locke dated 09-NOV-2016 directing that the parties' request for an extension of time to serve and file the pleadings brief and proposed agenda for the trial management/case management conference scheduled on November 21, 2016 is granted to November 11, 2016. The parties are asked to provide the documents electronically to cmt_ottawa@cas-satj.gc.ca as November 11 is a statutory holiday and the Registry is closed placed on file on 09-NOV-2016 Confirmed in writing to the party(ies)

Draft Order concerning timetable on consent (sent to the CMJ on 7-Nov-2016) received on 07-NOV-2016

Ottawa 02-NOV-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Continuation of the Motion Doc. No. 68 on behalf of Plaintiff Result of Hearing: Matter partially granted Before the Court: Case Management Conference Result of Hearing: draft order will be provided by counsel for Apotex, on consent, re: outcome of the CMC held in Court by way of video conference Senior Usher: Shawn Young Duration per day: 02-NOV-2016 from 10:00 to 11:45 Courtroom : Videoconference Room 703 - 7th Floor - Thomas D'Arcy McGee Bldg. - Ott Court Registrar: Julie Dulac Total Duration: 1h45min Appearances: Jerry Topolski 416-979-2211 representing Plaintiff Andrew Mandlsohn and Kevin Siu 416-593-5514 representing Defendant Comments: Outcome of CMC: The parties are advised that the trial judge will be Mr. Justice Locke. A TMC/CMC is scheduled on November 21, 2016, in Toronto, at 10:00 am for 2h. Parties agree on following schedule for exchange of expert reports: in chief: 25-Nov-2016, in response: 3-Feb-2017, in reply with motions for leave if any by 3-Mar-2017. Timing of PTC and content of PTC material and timing of it will be discussed at the CMC of 21-Nov-2016. The parties will provide the trial judge with a pleadings brief, an agenda and any agreed upon documents they feel the judge should have for the TMC by 9-Nov-2016. The pleadings brief provided in the context of the motions to compel in T-389-11 (ID 194) will be provided to the trial judge for the TMC. The drop dead date for exchange of document etc is 3-Feb-2017. This hearing was recorded using a back-up recorder Minutes of Hearing entered in Vol. 961 page(s) 50 - 54 Abstract of Hearing placed on file

Solicitor's certificate of service on behalf of Andrew Mandlsohn confirming service of ID 206 upon Plaintiff by e-mail on 31-OCT-2016 filed on 31-OCT-2016

Public Version of Motion Record of Astrazeneca Canada Inc. (Doc 66, ID 193) received on 31-OCT-2016

Letter from Defendant dated 28-OCT-2016 advising that they will appear by Video conference on November 2, 2016 received on 28-OCT-2016

Communication to the Court from the Registry dated 28-OCT-2016 re: the Plaintiff's correspondence dated 27-Oct-2016

Letter from Plaintiff dated 27-OCT-2016 providing mutual dates of availability for a trial management/case management conference in November or December received on 27-OCT-2016

Toronto 26-OCT-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 64 on behalf of Defendant Result of Hearing: Matter partially granted Before the Court: Motion Doc. No. 68 on behalf of Plaintiff Result of Hearing: Matter partially granted Matter adjourned to Special Sitting in Ottawa on 02-NOV-2016 to begin at 10:00 held in Court Senior Usher: Lisa Tirado Duration per day: 26-OCT-2016 from 09:32 to 03:58 Courtroom : Courtroom No. 7-A - Toronto Court Registrar: Christine McCullough Total Duration: 1d Appearances: Jerry Topolski / Michael Yasskin (416) 979-2211 representing Plaintiff Andrew Mandlsohn/ Kevin Siu (416) 593-5514 representing Defendant Comments: parties to provide dates for a joint CMC/TMC in November or December by the end of the week. DARS HEARING: Z006692 Minutes of Hearing entered in Vol. 960 page(s) 332 - 338 Abstract of Hearing placed on file

Affidavit of service of Sadaf Adelpur sworn on 20-OCT-2016 on behalf of Plaintiff confirming service of docs. 69, 71 and Joint Book of Authorities upon Defendant by courier on 20-OCT-2016 filed on 20-OCT-2016

Joint Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff Defendant received on 20-OCT-2016

Sealed envelope pursuant to Order dated 12-MAY-2016 on behalf of Plaintiff purporting to contain Plaintiff's motion record with attached confidential schedules Filed on 20-OCT-2016

****** CANCELLED ****** Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Toronto on 26-OCT-2016 to begin at 09:30 for an Order requiring a representative of the Defendant to respond to questions undertaken to be responded to and to respond to questions improperly refused or taken under advisement at the examination for discovery of Mark Findlay (CONFIDENTIAL VERSION) filed on 20-OCT-2016

Motion Record containing the following original document(s): 68 Number of copies received: 3 on behalf of Plaintiff filed on 20-OCT-2016

Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Toronto on 26-OCT-2016 to begin at 09:30 for an Order requiring a representative of the Defendant to respond to questions undertaken to be responded and to respond to questions improperly refused or taken under advisement at the examination for discovery of Mark Findlay; and other relief (PUBLIC VERSION) filed on 20-OCT-2016

Solicitor's certificate of service on behalf of Andrew Mandlsohn confirming service of doc. 66 and Pleadings Brief upon Plaintiff by email on 20-OCT-2016 filed on 20-OCT-2016

Pleadings Brief (Re: Apotex and AstraZeneca's Motions to Compel Flowing from Second Round of Examination for Discovery, returnable on October 26, 2016) received on 20-OCT-2016

Motion Record containing the following original document(s): 64 65 Number of copies received: 3 on behalf of Defendant filed on 20-OCT-2016

Affidavit of Kingsley W. Koo sworn on 04-OCT-2016 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 64 with Exhibits A-C (Exh. C is in sealed envelope) filed on 20-OCT-2016

Notice of Motion contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Toronto on 26-OCT-2016 to begin at 09:30 for an Order requiring Apotex Inc. to answer outstanding questions from the examination of Mr. Gordon Fahner; and other relief (Schedule A to Notice of Motion in sealed envelope) filed on 20-OCT-2016

Memorandum to file from Julie Dulac dated 07-OCT-2016 I spoke to counsel for Apotex today re: the fact that the draft order arising out of the CMTC of September 15th has not been submitted yet. He advised that the parties have agreed to all paragraphs of the draft order excet one and their intention is to discuss the issue with the Court at the hearing of the motion for 2nd round examinations scheduled on the 26-Oct- 2016 in Toronto. The parties will be filing their materials re: motions for 2nd round examinations on October 20th by noon as requested by the Court placed on file.

Ottawa 15-SEP-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss scheduling hearing of second round discovery motions Result of Hearing: The motions will be heard in Toronto on October 26, 2016 at 9:30 for 1 day. held in chambers by way of Conference Call Duration per day: 15-SEP-2016 from 02:10 to 02:17 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 7min Appearances: Jerry Topolski 416-597-5907 representing Apotex Gunars Gaikis and Andrew Mandlsohn 416-595-2755 representing AstraZeneca Draft Decision to be submitted by Apotex Minutes of Hearing entered in Vol. 957 page(s) 269 - 270 Abstract of Hearing placed on file

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 6-Sep-2016 placed on file on 07-SEP-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 07-SEP-2016 directing that a case management telephone conference will be held at 2:00 pm on September 15, 2016 to discuss and set a schedule for the matters discussed in counsel's September 6, letter placed on file on 07-SEP-2016 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 06-SEP-2016 re: Apotex's correspondence dated 6-Sep-2016

Letter from Apotex dated 06-SEP-2016 requesting a CMC to discuss scheduling of motions re: second round examinations and requesting an amendment to the timetable received on 06-SEP-2016

Request for Copy of Audio Recording of a Federal Court Hearing on behalf of Defendant received on 27-JUL-2016

Letter from Defendant dated 27-JUL-2016 This letter states that Smart & Biggar has changed their address to: 1100-150 York Street, Toronto, ON, M5H 3S5 received on 28-JUL-2016

Affidavit of service of Darlene Power sworn on 13-JUN-2016 on behalf of Plaintiff confirming service of doc. #62 upon Defendant by telecopier on 13-JUN-2016 filed on 13-JUN-2016

Notice of abandonment of motion Motion Doc. No. 56 on behalf of Plaintiff filed on 13-JUN-2016

Certified French language Translation of ORDER AND REASONS rendered on 16-MAY-2016 by Mireille Tabib, Prothonotary filed on 15-JUN-2016 pursuant to s. 20 of the Official Languages Act. Copy of Translation of Reasons for ORDER AND REASONS entered in J. & O. Book, volume 1303 page(s) 205 - 206

Affidavit of service of SADAF ADELPUR sworn on 07-JUN-2016 on behalf of Plaintiff confirming service of DOCS 58 & 59 upon Defendant by courier on 07-JUN-2016 filed on 07-JUN-2016

Consent on behalf of BOTH PARTIES to EXTENSION TO 7-JUN-2016 FOR PLAINTIFF TO SERVE/FILE 2ND AMENDED REPLY filed on 07-JUN-2016

Amended Reply(second amended) on behalf of Plaintiff Filed on 07-JUN-2016

Ottawa 03-JUN-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss issues raised in Apotex's correspondence dated May 30, 2016 and June 2, 2016 Result of Hearing: The Court encouraged the parties to have a discussion off line and attempt to resolve issues and offered dates for hearing any motions if they are unable to resolve them held in chambers by way of Conference Call Duration per day: 03-JUN-2016 from 08:30 to 09:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 35min Appearances: Jerry Topolski 416-597-5907 representing Plaintiff Gunars Gaikis 416-595-2755 representing Defendant Minutes of Hearing entered in Vol. 952 page(s) 342 - 345 Abstract of Hearing placed on file

Letter from Plaintiff dated 02-JUN-2016 bringing to the Court's attention issues re: affidavit of documents and asking that it be discussed at the CMC scheduled 3-Jun-2016 received on 02-JUN-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 1-Jun-2016 placed on file on 01-JUN-2016

Letter from Defendant dated 30-MAY-2016 advising it will serve its supplementary affidavit of documents accompanied by the additionally listed documents on June 1, 2016 with a sworn copy to follow received on 30-MAY-2016

Letter from Plaintiff dated 30-MAY-2016 requesting an urgent CMC to address the Defendant's Second Amended Statement of Defence received on 30-MAY-2016

Affidavit of service of Darlene Power sworn on 26-MAY-2016 on behalf of Plaintiff confirming service of doc 56 upon Defendant by telecopier on 26-MAY-2016 filed on 26-MAY-2016

Notice of Motion on behalf of Plaintiff A DATE TO BE SET BY THE COURT for an appeal of the decision of Mireille Tabib, Prothonotary dated 16-MAY-2016 filed on 26-MAY-2016

Affidavit of service of Kingsley W. Koo sworn on 26-MAY-2016 on behalf of Defendant confirming service of Doc 54 upon Plaintiff by telecopier on 26-MAY-2016 filed on 26-MAY-2016

Amended Defence on behalf of Astrazeneca (Second Amended) filed on 26-MAY-2016

Acknowledgment of Receipt received from both parties with respect to the decision of the Court dated 20-May-2016 placed on file on 20-MAY-2016

Order dated 20-MAY-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 39 Result: dismissed under reserve of AstraZeneca's rights to seek appropriate relief from the trial judge if the decision of the Supreme Court in SCC case case number 36654 is not rendered before the end of the trial in T-389-11. Costs in the amount of $3,500.00 shall be payable by AstraZeneca to Apotex Filed on 20-MAY-2016 copies sent to parties entered in J. & O. Book, volume 1301 page(s) 277 - 281 Interlocutory Decision

Acknowledgment of Receipt received from both parties with respect to the Reasons and Order of the Court dated 16-May-2016 placed on file on 16-MAY-2016

Reasons for Order and Order dated 16-MAY-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 32 Result: granted Filed on 16-MAY-2016 copies sent to parties Interlocutory Decision Certificate of Order entered in J. & O. Book, volume 1301 page(s) 160 - 161

Toronto 10-MAY-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 32 on behalf of Defendant Result of Hearing: Matter reserved Before the Court: Motion Doc. No. 39 on behalf of Defendant Result of Hearing: Matter reserved held in Court Senior Usher: Fred Lloyd Duration per day: 10-MAY-2016 from 09:03 to 15:57 Courtroom : Courtroom No. 7-B - Toronto Court Registrar: Jacqueline Smith Total Duration: 5h 41min Appearances: Jerry Topolski 416-979-2211 representing Plaintiff Michael Yasskin 416-979-2211 representing Plaintiff Gunars Gaikis 416-593-5514 representing Defendant Kevin Siu 416-593-5514 representing Defendant Comments: DARS:Z006699 Minutes of Hearing entered in Vol. 951 page(s) 266 - 271 Abstract of Hearing placed on file

Affidavit of service of Dadaf Adelpur sworn on 06-MAY-2016 on behalf of Plaintiff confirming service of doc. 50 and book of authorities upon Defendant by courier on 06-MAY-2016 filed on 06-MAY-2016

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 06-MAY-2016

Motion Record in response to Motion Doc. No. 39 containing the following original document(s): 48 49 Number of copies received: 3 on behalf of Plaintiff filed on 06-MAY-2016

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 39 filed on 06-MAY-2016

Affidavit of Christopher Rootham sworn on 27-APR-2016 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 39 with Exhibits a-b filed on 06-MAY-2016

Affidavit of service of Judy Adamcyzk sworn on 29-APR-2016 on behalf of Plaintiff confirming service of Doc. No. 46 and Book of Authorities upon Defendant by courier on 29-APR-2016 filed on 29-APR-2016

Book of Authorities consisting of 1 volume(s) on behalf of Plaintiff received on 29-APR-2016

Motion Record in response to Motion Doc. No. 32 containing the following original document(s): 44 45 Number of copies received: 3 on behalf of Plaintiff filed on 29-APR-2016

Written Representations contained within a Motion Record on behalf of Plaintiff concerning Motion Doc. No. 32 filed on 29-APR-2016

Affidavit of Nicole Roth sworn on 28-APR-2016 contained within a Motion Record on behalf of Plaintiff in opposition to Motion Doc. No. 32 with Exhibits "A"-"E" filed on 29-APR-2016

Solicitor's certificate of service on behalf of Kevin P Siu confirming service of Doc 42 upon Plaintiff by personal service on 19-APR-2016 filed on 19-APR-2016

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 19-APR-2016

Motion Record containing the following original document(s): 39 40 41 Number of copies received: 3 on behalf of Defendant filed on 19-APR-2016

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 39 filed on 19-APR-2016

Affidavit of Kingsley W. Koo sworn on 19-APR-2016 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 39 with Exhibits A-F filed on 19-APR-2016

Notice of Motion contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Toronto on 10-MAY-2016 to begin at 09:00 for an Order that the actions in T-1668-10 and this matter be stayed until the decision in the SCC Case No 36654 (Gunars Gaikis 416-593-5514) filed on 19-APR-2016

Affidavit of service of Judy Adamczyk sworn on 19-APR-2016 on behalf of Plaintiff confirming service of doc 37 upon Defendant by telecopier on 19-APR-2016 filed on 19-APR-2016

Consent on behalf of Plaintiff to electronic service of documents in this action that are not required to be served personally filed on 19-APR-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 8-Apr-2016 placed on file on 12-APR-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 08-APR-2016 directing that the motion to amend, initially scheduled for May 5, 2016, is rescheduled to May 10, 2016, in Toronto beginning at 9:00 a.m. Apotex's responding motion record to Astra's moiton to amend to be served and filed on April 29, 2016. Astra's motion record on a motion for a stay to be served and filed by April 19, 2016. Apotex's responding affidavit, if any, to be served by April 29, 2016. Apotex's full responding record and Astra's supplementary submissions arising out of cross-examinations (if any) to be served and filed by May 6, 2016. Astra's motion for a stay will be heard immediately after the motion to amend, on May 10, 2016 placed on file on 11-APR-2016 Confirmed in writing to the party(ies)

Ottawa 08-APR-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss AstraZeneca's proposed motion for stay Result of Hearing: Direction to follow held in chambers by way of Conference Call Duration per day: 08-APR-2016 from 10:30 to 11:20 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 50min Appearances: Jerry Topolski and Michael Yasskin 416-597-5907 representing Plaintiff Gunars Gaikis and Kevin Siu 416-593-5514 representing Defendant Minutes of Hearing entered in Vol. 949 page(s) 345 - 347 Abstract of Hearing placed on file

Letter from Defendant dated 08-APR-2016 ENCLOSED MOTION(DOC 35) FILED PURSUANT TO DIRECTIONS OF P.TABIB DATED 9-MAR-2016 AND 8-APR-2016... received on 08-APR-2016

Solicitor's certificate of service on behalf of KEVIN P.SIU confirming service of DOC 35 and AUTHORITIES upon Plaintiff by personal service on 08-APR-2016 filed on 08-APR-2016

Book of Authorities consisting of 1 volume(s) on behalf of Defendant received on 08-APR-2016

Motion Record containing the following original document(s): 32 33 34 Number of copies received: 3 on behalf of Defendant filed on 08-APR-2016

Written Representations contained within a Motion Record on behalf of Defendant concerning Motion Doc. No. 32 filed on 08-APR-2016

Affidavit of KINGSLEY W.KOO (WITH EX A & B SEALED-PURSUANT TO 12-MAY-2015 ORDER) sworn on 08-APR-2016 contained within a Motion Record on behalf of Defendant in support of Motion Doc. No. 32 with Exhibits A-D filed on 08-APR-2016

Notice of Motion contained within a Motion Record on behalf of Defendant returnable at Special Sitting in Toronto on 10-MAY-2016 to begin at 09:00 for an Order TO AMEND THEIR AMENDED STMNT OF DEFENCE; COSTS OF THE MOTION filed on 08-APR-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 5-Apr-2016 placed on file on 05-APR-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 05-APR-2016 directing that a case management telephone conference will be held at 10:30 am on April 8, 2016 placed on file on 05-APR-2016 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 05-APR-2016 re: the parties correspondence dated 1-Apr-2016 (ID 130) and April 4, 2016 (ID 131)

Letter from Apotex dated 04-APR-2016 in response to AstraZeneca's correspondence dated 1-Apr-2016 re: motion for stay received on 04-APR-2016

Letter from AstraZeneca dated 01-APR-2016 advising that AstraZeneca Intends to move for a stay of these proceedings pending the outcome of an appeal to the Supreme Court of Canada tentatively scheduled on November 8, 2016 received on 01-APR-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated April 1, 2016 placed on file on 04-APR-2016

Acknowledgment of Receipt received from both parties with respect to the Orders of the Court dated 1-Apr-2016 (ID 125 and 126) placed on file on 01-APR-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 01-APR-2016 directing that further to the Defendant's correspondence dated 23-Mar-2016 requesting an extension of the current deadline of March 25, 2016 to exchange outstanding questions agreed to be answered and ordered to be answered arising from both parties' examinations for discovery "extension granted as requested" placed on file on 01-APR-2016 Confirmed in writing to the party(ies)

Order dated 01-APR-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 24 Result: granted in part Filed on 01-APR-2016 copies sent to parties entered in J. & O. Book, volume 1297 page(s) 273 - 275 Interlocutory Decision

Order dated 01-APR-2016 rendered by Mireille Tabib, Prothonotary Matter considered with personal appearance The Court's decision is with regard to Motion Doc. No. 27 Result: granted in part Filed on 01-APR-2016 copies sent to parties entered in J. & O. Book, volume 1297 page(s) 267 - 272 Interlocutory Decision

Letter from Defendant dated 01-APR-2016 in response to the Plaintiff's correspondence of 30-Mar-2016 (sent to the CMJ on 1-Apr-2016) received on 01-APR-2016

Letter from Plaintiff dated 30-MAR-2016 in response to the Defendant's correspondence dated 29-Mar-2016 (sent to the CMJ on 31-Mar-2016) received on 31-MAR-2016

Communication to the Court from the Registry dated 29-MAR-2016 re: ID 114, 115, 120 and 121

Letter from Defendant dated 29-MAR-2016 attaching a draft order re: motion 27 and advising that the parties do not agree on the outcome of question 90 received on 29-MAR-2016

Letter from Plaintiff dated 23-MAR-2016 requesting a reciprocal extension to March 30, 2016 to exchange outstanding questions agreed to be answered and ordered to be answered received on 23-MAR-2016

Covering letter from Defendant dated 22-MAR-2016 concerning Doc. No. 28 placed on file on 22-MAR-2016

Affidavit of service of Kingsley W. Koo sworn on 22-MAR-2016 on behalf of Defendant confirming service of Doc 28 upon Plaintiff by telecopier on 22-MAR-2016 filed on 22-MAR-2016

Consent on behalf of Defendant to electronic service of all documents in this action that are not required to be served personally filed on 22-MAR-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated March 9, 2016 placed on file on 11-MAR-2016

Covering letter from Plaintiff dated 17-MAR-2016 concerning draft order re: motion doc 24 placed on file on 17-MAR-2016

Draft Order concerning Motion Doc. No. 24 received on 17-MAR-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 10-MAR-2016 directing that the motion may be made returnable in Ottawa beginning at 9:30 am on May 5, 2016, the parties are to advise as to the expected duration in due course placed on file on 11-MAR-2016 Confirmed in writing to the party(ies)

Ottawa 09-MAR-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss schedule proposed by AstraZeneca in its correspondence dated 2-Mar-2016 Result of Hearing: a schedule is set and the Court gives the parties her dates of availability for the hearing of any motion to amend. The parties will communicate their availability shortly. A draft order will be submitted held in chambers by way of Conference Call Duration per day: 09-MAR-2016 from 03:00 to 04:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Jerry Topolski and Michael Yasskin 416-597-5907 representing Plaintiff Andrew Mandhelson and Kevin Siu 416-593-5514 representing Defendant Draft Decision to be submitted by both parties Minutes of Hearing entered in Vol. 947 page(s) 447 - 449 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 08-MAR-2016 re: in preparation for the CMC schedule to take place on 9-Mar-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated March 7, 2016 placed on file on 08-MAR-2016

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 07-MAR-2016 directing that a case management conference will take place on March 9, 2016 at 3:00 placed on file on 07-MAR-2016

Communication to the Court from the Registry dated 07-MAR-2016 re: the Defendant's correspondence dated 2-Mar-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 29-Feb-2016 placed on file on 01-MAR-2016

Letter from Defendant dated 02-MAR-2016 further to the parties' motions to compel heard February 25th and the Direction dated February 29th. Parties have been unable to reach an agreement regarding a timetable, which was to be submitted to the Court today. As such, AstraZeneca has psovided its proposed timetable.... The Defendant seeks a case management teleconference to discuss the parties proposed timetables... received on 02-MAR-2016

(Sealed) Notice of Motion on behalf of Defendant returnable at Special Sitting in Toronto on 25-FEB-2016 to begin at 09:30 for to compel answers from first round examinations for discovery, returnable February 25, 2016 filed on 19-FEB-2016

Written directions received from the Court: Mireille Tabib, Prothonotary dated 29-FEB-2016 directing that "for the parties' information and ease of preparation of a draft consent order, the following is an edited version of the determination made orally at the hearing of February 25, 2016:...(see Direction for the rest) placed on file on 29-FEB-2016 Confirmed in writing to the party(ies)

Toronto 25-FEB-2016 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Motion Doc. No. 24 on behalf of Plaintiff Result of Hearing: Various questions asked and answered see minutes for details. Before the Court: Motion Doc. No. 27 on behalf of Defendant Result of Hearing: Various questions asked and answered see minutes for details held in Court Senior Usher: Lisa Tirado Duration per day: 25-FEB-2016 from 09:28 to 03:58 Courtroom : Courtroom No. 4-B - Toronto Court Registrar: Andrew Murray Total Duration: 6h Appearances: Jerry Topolski 416-479-2211 representing Plaintiff Michael Yasskin 416-479-2211 representing Plaintiff Andrew Mandlsohn 416-593-5514 representing Defendant Kevin Siu 416-593-5514 representing Defendant Comments: DARS used Z009121, see minutes for specific answers to questions. Parties to submit a schedule on Wednesday March 2nd. Minutes of Hearing entered in Vol. 947 page(s) 44 - 52 Abstract of Hearing placed on file

Memorandum to file from Julie Dulac dated 24-FEB-2016 counsel for Apotex sent an e-mail advising that its refusals motion scheduled to be heard in Toronto on 25-Feb-2016 is reduced to Item Nos: 1-2, 5-8, 10, 13-14 which only require the Court to make an order on consent, and item 20 for an expected duration of 45 min. Counsel for AstraZeneca e-mailed to advise that its motion is reduced to Item Nos: 32, 33, 35, 39-44 46, 48-49, 51-52, 56,57, 69, 72, 74, 75, 86, 90, 92, 96-97, 152, 176, 180, 234, 240 with an expected duration of 1.5h. The CMJ and Registry Officer have been advised. placed on file.

Covering letter from Plaintiff dated 19-FEB-2016 concerning Doc. Nos. 23 24 25 26 placed on file on 19-FEB-2016

Solicitor's certificate of service on behalf of Michael Yasskin confirming service of Docs 23, 24,25 upon Defendant by courier on 18-FEB-2016 filed on 19-FEB-2016

Motion Record containing the following original document(s): 24 Number of copies received: 3 on behalf of Plaintiff filed on 19-FEB-2016

Notice of Motion contained within a Motion Record on behalf of Plaintiff returnable at Special Sitting in Toronto on 25-FEB-2016 to begin at 09:30 for an order to re-attend forexamination for discovery. filed on 19-FEB-2016

Joint Pleadings Brief filed on 19-FEB-2016

Covering letter from Plaintiff dated 19-FEB-2016 concerning document id 92 93 94 95 placed on file on 19-FEB-2016

Solicitor's certificate of service on behalf of Kevin P. Siu confirming service of document id 92, 93 and 94 upon Defendant by personal service on 19-FEB-2016 filed on 19-FEB-2016

Joint Book of Authorities consisting of 2 volume(s) on behalf of Plaintiff Defendant received on 19-FEB-2016

Sealed envelope pursuant to order of the Court dated May 12, 2016 on behalf of Defendant purporting to contain Affidavit of Kingsley K. Koo Filed on 19-FEB-2016

Sealed envelope pursuant to order dated May 12, 2015 on behalf of Defendant purporting to contain (doc 27) Notice of Motion to compel answers returnable February 25, 2016. Filed on 19-FEB-2016

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 9-Dec-2015 placed on file on 09-DEC-2015

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 09-DEC-2015 directing that Refusals motions will be heard in Toronto,on February 25,2016 beginning at 9:30 a.m. for one day. The material is to be served and filed as per a schedule to be agreed to by the parties but ensuring that all materials are in Ottawa by February 19, 2016 placed on file on 09-DEC-2015

Ottawa 09-DEC-2015 BEFORE Mireille Tabib, Prothonotary Language: E Before the Court: Case Management Conference to discuss the briefing and scheduling of the refusals motions re: first round discovery Result of Hearing: the motions are scheduled to proceed on February 25, 2016 at 9:30 a.m. in Toronto. Material to be serve and filed by February 19 in Ottawa held in chambers by way of Conference Call Duration per day: 09-DEC-2015 from 10:00 to 10:10 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 10min Appearances: Jerry Topolski and Michael Yasskin 416-597-5907 representing Plaintiff Gunars Gaikis and Andrew Mandhelson 416-593-5514 representing Defendant Comments: The Court agreed with the parties' suggestion to only file Notices of motion, copy of pleadings and refusals charts (no traditional motion record needed) Minutes of Hearing entered in Vol. 942 page(s) 279 - 280 Abstract of Hearing placed on file

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 3-Dec-2015 placed on file on 04-DEC-2015

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 03-DEC-2015 directing that a case management conference by telephone conference will be held at 10:00 a.m. December 9, 2015 to fix a date for refusals motions. The request for an extension of time until January 13, 2016 to provide answers to undertakings is granted placed on file on 03-DEC-2015 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 03-DEC-2015 re: the Plaintiff's correspondence dated 2-Dec-2015

Letter from Plaintiff dated 02-DEC-2015 providing dates of availability for a CMC and for the hearing of the refusals motions as well as asking for an extension of time for answers to undertakings received on 03-DEC-2015

Acknowledgment of Receipt received from both parties with respect to the Orders of the Court dated 12-May-2015 placed on file on 13-MAY-2015

Protective Order dated 12-MAY-2015 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 30-APR-2015 Result: See Order for details Filed on 13-MAY-2015 copies sent to parties entered in J. & O. Book, volume 1266 page(s) 327 - 336 Interlocutory Decision

Confidentiality Order dated 12-MAY-2015 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff - dated 30-APR-2015 Result: See Order for details Filed on 13-MAY-2015 copies sent to parties entered in J. & O. Book, volume 1266 page(s) 324 - 326 Interlocutory Decision

Draft confidentiality and protective order (revised) concerning Direction dated May 6, 2015 (sent to the CMJ on 11-May-2015) received on 11-MAY-2015

Acknowledgment of Receipt received from both parties with respect to the Direction of the Court dated 6-May-2015 placed on file on 07-MAY-2015

Oral directions received from the Court: Mireille Tabib, Prothonotary dated 06-MAY-2015 directing that given the evolution of the Court's practice as concerns confidentiality and protective orders, the Court is not prepared to issue a confidentiality as wide as the proposed order; The Court is prepared to issue a protective order governing the manner in which the parties are to treat information exchanged between them, and a limited confidentiality order allowing the parties to file documents and discovery transcripts under seal if they are filed in support of motions to compel, and subject to the Court's discretion as to the maintenance of confidentiality at or following motions to compel. Filings for any other purpose could not be made under seal without seeking a further confidentiality order. The parties are to either submit revised draft orders or make a formal motion for a confidentiality order placed on file on 06-MAY-2015 Confirmed in writing to the party(ies)

Acknowledgment of Receipt received from both parties with respect to the Order of the Court dated 24-Apr-2015 placed on file on 05-MAY-2015

Communication to the Court from the Registry dated 05-MAY-2015 re: the Plaintiff's letter dated April 30, 2015

Letter from Plaintiff dated 30-APR-2015 requesting the issuance of the proposed Confidentiality Order received on 30-APR-2015

Order dated 24-APR-2015 rendered by Mireille Tabib, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 02-APR-2015 re: proposed timetable Result: 1. The parties shall exchange affidavits of documents by may 15, 2015. 2. The parties shall complete the first round of discoveries by October 15, 2015. 3. The parties shall answer undertakings by December 15, 2015. 4. The parties shall request a case management telephone conference to schedule refusals motions by December 21, 2015. The request shall include the parties' mutual dates of availability for a case management telephone conference and for the hearing of the motion in January and February 2016. 5. The parties shall complete the second round of discoveries by April 29, 2016. 6. The parties shall answer undertakings from the second round of discoveries by June 15, 2016. 7. The parties shall request a case management telephone conference to schedule refusals motions for the second round by June 20, 2016. The request shall include the parties' mutual dates of availability for the case management telephone conference and for the hearing of the motions in July and August 2016. 8. Expert reports in chief (AstraZeneca on infringement and Apotex on s. 8 and invalidity) shall be served and filed, as pre-trial conference materials, by October 21, 2016. 9. Apotex shall serve and file a requisition for trial and a pre-trial conference memorandum by October 21, 2016. 10. Responding expert reports shall be served and filed, as pre-trial conference materials, by December 30, 2016. 11. AstraZeneca shall serve and file its pre-trial conference memorandum by December 30, 2016. 12. The parties shall serve and file motions for leave to rely on reply expert reports by February 2, 2017. 13. The trial of this matter shall take place in Toronto, beginning at 9:30 a.m. on May 8, 2017, for a duration of 30 days Filed on 24-APR-2015 copies sent to parties entered in J. & O. Book, volume 1264 page(s) 421 - 423 Interlocutory Decision

Revised draft order re: proposed timetable submitted further to the Court's instructions dated 21-Apr-2015 placed on file on 23-APR-2015

Memorandum to file from Julie Dulac dated 22-APR-2015 the Court asked counsel to re-draft the Order re: proposed timetable. I advised Mr. Shogilev's assistant on 22-Apr-2015 placed on file.

Draft Order concerning proposed timetable consented to by all parties received on 22-APR-2015

Communication to the Court from the Registry dated 07-APR-2015 re: the Plaintiff's correspondence dated 2-Apr-2015

Letter from Plaintiff dated 02-APR-2015 providing a proposed timetable and a consolidated trial chart received on 02-APR-2015

Confirmation from both parties of receipt of the Order issued on March 26, 2015 placed on file on 26-MAR-2015

Order dated 26-MAR-2015 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Case Management Conference Result: THIS COURT ORDERS that: 1. The action in Federal Court File No. T-389-11 and the action in Federal Court File No. T-1668-10, as it relates to Canadian Patent No. 2,193,944, are consolidated for the purpose of being heard together or consecutively by the same judge. 2. The trial of these matters shall take place before the Court at 180 Queen Street West, in the City of Toronto, Ontario, commencing on the 8th day of May, 2017, at 9:30 in the forenoon for a duration of thirty (30) days such trial being heard four (4) days per week; 3. The trial shall be conducted in English. 4. This order is made without prejudice to either party seeking to have the actions formally consolidated; 5. By no later than ten (10) days from the date of the appointment of a case management judge, parties shall submit a timetable on consent for further steps in the proceeding. Filed on 26-MAR-2015 copies sent to parties entered in J. & O. Book, volume 1262 page(s) 156 - 157 Interlocutory Decision

Letter from Defendant dated 25-MAR-2015 Providing the Court with a draft order on consent setting down the trial received on 25-MAR-2015

Acknowledgment of Receipt received from all parties (by e-mail) with respect to the Order of the Court dated 23-MAR-2015 placed on file on 24-MAR-2015

Order dated 23-MAR-2015 rendered by Chief Justice Crampton Matter considered without personal appearance The Court's decision is with regard to Special Case Result: "IT IS ORDERED pursuant to Rule 383 that Prothonotary Mireille Tabib is assigned as Case Management Judge in the place of Prothonotary Roza Aronovitch in this matter." Filed on 23-MAR-2015 copies sent to parties entered in J. & O. Book, volume 1261 page(s) 452 - 452 Interlocutory Decision

Ottawa 17-MAR-2015 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss setting trial dates and scope of trial Result of Hearing: this matter is partially consolidated for trial purposes with another T-1668-11 and the trial will begin on May 8, 2017 for 30 days. Order to follow. The parties are to request a CMC within 10 days of Madam Tabib's appointment as the new CMJ, to fix a timetable for the proceeding. The parties are asked to provide wording re: the scope of the consolidation for trial held in chambers Duration per day: 17-MAR-2015 from 10:00 to 11:05 Courtroom : Judge's Chambers - Ottawa Court Registrar: Julie Dulac Total Duration: 1h Appearances: Sandon Shogilev 416-979-2211 representing Apotex Inc. Urszula Wojtyra and Gunars Gaikis 416-593-5514 representing AstraZeneca Inc. Minutes of Hearing entered in Vol. 924 page(s) 184 - 187 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 12-MAR-2015 re: Preparation of the file for the case conference on March 17, 2015

Letter from Plaintiff dated 11-MAR-2015 providing the Court with submissions for the case conference scheduled for March 17, 2015 received on 11-MAR-2015

Letter from Defendant dated 11-MAR-2015 providing the Court with submissions for the case conference scheduled for March 17, 2015 received on 11-MAR-2015

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-MAR-2015 directing that The case management conference by teleconference scheulde for March 6, 2015 is hereby adjourned to March 17, 2015, commencing at 10:00 for one one hour. By March 11, 2015, parties are to file joint or separate submissions regarding the need to consolidate the two actions, if any, a single consolidated Trial Chart; and a Timetable on consent for the prosecution of the combined or consolidated actions, as the case may be. Each of the Trial Chart and the Timetable is to integrate the further prosecution of issues arising from the '653 patent following a sucessful appeal of Justice Rennie's decision, if any. placed on file on 02-MAR-2015 Confirmed in writing to the party(ies)

confirmation from both counsel of receipt of the Direction issued on February 13, 2015. placed on file on 13-FEB-2015

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 13-FEB-2015 directing that A case conference is fixed for 10:00 a.m. on March 6, 2015, by teleconference. By March 2, 2015, parties are to file: joint or separate submissions regarding the need to consolidate the two actions, if any; a single consolidated Trial Chart and a Timetable on consent for the prosecution of the combined or consolidated actions, as the case may be. Each of the Trial Chart and the Timetable is to integrate the further prosecution of issues arising from the '653 patent following a successful appeal of Justice Rennie's decision, if any. placed on file on 13-FEB-2015 Confirmed in writing to the party(ies)

Toronto 06-FEB-2015 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference Result of Hearing: Matter adjourned sine die held in person Senior Usher: Desmond Howard Duration per day: 06-FEB-2015 from 09:30 to 10:37 Courtroom : Conference Room No. 5-43 - Toronto Court Registrar: Jena Russell Total Duration: 1hr 7 min Appearances: Sandon Shogilev 416-979-2211 representing Plaintiff Gunnars Gaikis 416-593-5514 representing Defendant Urszula Wojtyra 416-593-5514 representing Defendant Comments: Court directs that a new joint trial chart to be produced in T-1668-10 and that submissions be provided explaining outstanding issues Parties will be contacted to set up another CMC within approximately 2 weeks Minutes of Hearing entered in Vol. 921 page(s) 428 - 429 Abstract of Hearing placed on file

Confirmation from both parties of reciept of the Direction issued on February 2, 2015 placed on file on 02-FEB-2015

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 02-FEB-2015 directing that The case management conference scheduled for February 2, 2015, in Toronto at 9:30 a.m. is adjourned to February 6, 2015, commencing at 9:30 a.m., in Toronto for two hours. placed on file on 02-FEB-2015 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 29-JAN-2015 directing that The timetable suggested by the parties in the correspondence dated November 18, 2014 is overtaken. Parties are to come prepared to discuss a revised timetable at the case conference set for February 2, 2015. placed on file on 29-JAN-2015 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 28-JAN-2015 re: preparation of the file for the case conference on February 2, 2015

Covering letter from Plaintiff dated 26-JAN-2015 concerning Doc. No. 14 placed on file on 26-JAN-2015

Issues for Trial and Trial Chart on behalf of Apotex filed on 26-JAN-2015

Affidavit of service of Michael Paciorek sworn on 26-JAN-2015 on behalf of Defendant confirming service of Doc 12 upon Plaintiff by telecopier on 26-JAN-2015 filed on 26-JAN-2015

Astrazeneca's Trial Chart (3 copies) filed on 26-JAN-2015

Confirmation from both counsel of receipt of the Direction dated January 12, 2015. placed on file on 12-JAN-2015

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 12-JAN-2015 directing that "The case management conference scheduled to be heard in person in Toronto on February 3, 2015 will now be heard on February 2, 2015, in Toronto, in person commencing at 9:30 for two hours." placed on file on 12-JAN-2015 Confirmed in writing to the party(ies)

Affidavit of service of DARLENE POWER sworn on 05-JAN-2015 on behalf of Plaintiff confirming service of DOC 10 upon Defendant by telecopier on 05-JAN-2015 filed on 05-JAN-2015

Amended Reply TO AMENDED STATEMENT OF DEFENCE on behalf of Plaintiff Filed on 05-JAN-2015

Affidavit of service of Michael Paciorek sworn on 05-DEC-2014 on behalf of Defendant confirming service of Doc 8 upon Plaintiff by telecopier on 05-DEC-2014 filed on 05-DEC-2014

Amended Defence filed on 05-DEC-2014

Confirmation from both counsel of receipt of the Direction dated December 2, 2014. placed on file on 03-DEC-2014

Written directions received from the Court: Roza Aronovitch, Prothonotary dated 02-DEC-2014 directing that THIS COURT DIRECTS that: 1. AstraZeneca shall serve and file an amended defence in Federal Court No. T-389-11 by December 5, 2014. 2. Apotex shall serve and file an amended reply in Federal Court File No. T-389-11 by January 5, 2015. 3. By January 26, 2015, each party shall serve and file a trial chart in respect of both above-noted proceedings, which shall include: a. a summary of pleadings, b. a statement of the issues for the trial of each proceeding for which the submitting party bears the burden, and c. a list of intended witnesses and the issues to which they will speak, and the estimated length of their testimony in chief and cross-examination. 4. A case management conference will be held in Toronto, in person on Tuesday, February 3, 2015, commencing at 9:30 a.m. placed on file on 03-DEC-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 26-NOV-2014 re: Correspondence dated November 21 and 26, 2014

Memorandum to file from Annette Houle, Ottawa dated 26-NOV-2014 The parties were informed that Madam Prothonotary Aronovitch was away from the office until the week of December 1, 2014 and that their correspondence would be placed before her at that time. placed on file.

Letter from Defendant dated 26-NOV-2014 Providing the Court with a draft direction on consent received on 26-NOV-2014

Letter from Defendant dated 26-NOV-2014 Providing the Court with their availability for a 25 day trial in 2017 received on 26-NOV-2014

Letter from Plaintiff dated 21-NOV-2014 Providing the Court with their availability for a 25 day trial in 2017 received on 21-NOV-2014

Ottawa 20-NOV-2014 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss a timetable and trial dates Result of Hearing: Ms Wojtyra will provide the Court with a new timetable and each party to write in with regards to trial dates and their availailability held by way of Conference Call Duration per day: 20-NOV-2014 from 10:00 to 10:00 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 10:30 Appearances: Mr. Topolski 416-979-2211 representing Plaintiff Ms Wojtyra and Mr. Mandleson 416-593-5514 representing Defendant Comments: Correspondence from the parties are due by November 26, 2014 Minutes of Hearing entered in Vol. 917 page(s) 290 - 295 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 19-NOV-2014 re: preparation of the file for the CMC on November 20, 2014

Letter from Defendant dated 18-NOV-2014 providing the Court with a proposed timetable and the length for trial for discussion at the case conference on November 20, 2014 received on 18-NOV-2014

Confirmation of receipt from both counsel of the Direction issued on Novemer 7, 2014. placed on file on 07-NOV-2014

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 07-NOV-2014 directing that Re: Letter dated November 5, 2014 on behalf of the defendant GRANTED. The draft timetable and number of days for trial is to be served and filed by November 18, 2014. placed on file on 07-NOV-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 06-NOV-2014 re: letter from the defendant dated November 5, 2014

Letter from Defendant dated 05-NOV-2014 requesting an extension of time to November 18, 2014 to provide the Court with a draft timetable. received on 05-NOV-2014

Ottawa 22-OCT-2014 BEFORE Roza Aronovitch, Prothonotary Language: E Before the Court: Case Management Conference to discuss a timetable Result of Hearing: The Court issues an Oral Directive that there would be another case conference on November 20, 2014 at 10:00 for one hour to discuss a timetable. held by way of Conference Call Duration per day: 22-OCT-2014 from 03:00 to 03:30 Courtroom : Judge's Chambers - Ottawa Court Registrar: Annette Houle Total Duration: 30min Appearances: Mr. Topolslki 1-416-979-2211 representing Plaintiff Ms Wojtyra/Mr. Mandelson 1-416-493-5514 representing Defendant Comments: Parties are to speak to each other and come up with a timetable on consent. Parties are also to speak to each other with regards to how long the trial would take. The draft timetable and length of trial is to be submitted by November 7, 2014 Minutes of Hearing entered in Vol. 915 page(s) 216 - 219 Abstract of Hearing placed on file

Communication to the Court from the Registry dated 21-OCT-2014 re: Preparation of the file for the case conference on October 22, 2014

Letter from Plaintiff dated 20-OCT-2014 providing the Court with issues for trial and a timetable for discussion at the case conference on October 22, 2014 received on 20-OCT-2014

Letter from Defendant dated 20-SEP-2014 providing the Court with issues for trial and a timetable for discussion at the case conference on October 22, 2014 received on 20-OCT-2014

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 16-SEP-2014 directing that There will be a case management conference, by teleconference on October 22, 2014, commencing at 3:00 for one hour. By October 20, 2014 parties are to provide their list of issues for trial and their submissions of a proposed timetable. placed on file on 16-SEP-2014 Confirmed in writing to the party(ies)

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 08-SEP-2014 directing that The case management conference scheduled for September 8, 2014 at 3:00 is adjourned to a date to be fixed by the Court. placed on file on 08-SEP-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 19-AUG-2014 re: Preparation of the file for the case conference on September 8, 2014.

confirmation of receipt from all parties of the Direction issued on August 15, 2014. placed on file on 15-AUG-2014

Oral directions received from the Court: Roza Aronovitch, Prothonotary dated 15-AUG-2014 directing that There will be a case management conference, by teleconference on September 8, 2014, commencing at 3:00 for one hour. placed on file on 15-AUG-2014 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 14-AUG-2014 re: by email providing the Court with the availability of the parties to attend a case management conference.

Memorandum to file from Julie Dulac dated 12-AUG-2014 further to Apotex's correspondence dated 01-Aug-2014, the CMJ asked that the parties availability for the weeks of September 8 and 15, 2014 be canvassed. I communicated with counsel by e-mail today asking them to provide such placed on file.

Communication to the Court from the Registry dated 07-AUG-2014 re: the plaintiff's letter dated 1-Aug-2014

Letter from Plaintiff dated 01-AUG-2014 pursuant to par. 3 of the Court's Order dated 8-Jul-2011 and to provide an update with respect to the proceeding received on 05-AUG-2014

Confirmation of receipt of all parties of the Direction dated July 29, 2013 placed on file on 31-JUL-2013

Oral directions received from the Court: Chief Justice Crampton dated 29-JUL-2013 directing that Madam Prothonotary Aronovitch will be on sabbatical from August 16, 2013 to December 30, 2013. In her absence, Madam Prothonotary Tabib is hereby assigned as case management judge in respect to the above noted file. Parties are to continue to send draft orders, directions and correspondence to cmt_ottawa@cas-satj.gc.ca. placed on file on 30-JUL-2013 Confirmed in writing to the party(ies)

Communication to the Court from the Registry dated 24-AUG-2011 re: Order of the Court dated August 9, 2011

Proof of Service of Fax received from All parties with respect to Doc. #7 (Order from the Acting Chief Justice Noël dated August 9, 2011). placed on file on 10-AUG-2011

Order dated 09-AUG-2011 rendered by Acting Chief Justice S Noël Matter considered without personal appearance The Court's decision is with regard to Order dated 08-JUL-2011 Result: Pursuant to Rule 383 that Prothonotary Roza Aronovitch is assigned as Case Management Judge in this matter. Filed on 09-AUG-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1131 page(s) 309 - 309 Interlocutory Decision

Communication to the Court from the Registry dated 03-AUG-2011 re: sent to Court for appointment of Case Management Judge

Order dated 08-JUL-2011 rendered by Roza Aronovitch, Prothonotary Matter considered without personal appearance The Court's decision is with regard to Letter from Plaintiff dated 05-JUL-2011 Result: 1. This proceeding shall continue as a specially managed proceeding. 2. The within proceeding shall be stayed until the determination of the validity and/or infringement of the Subject Patents in Court File No. T-1668-10. 3. The parties shall report to the Court on the status of the proceeding in Court File No. T-1668-10 no later than within thirty (30) days after the trial judgment therein. 4. There shall be no order as to costs. Filed on 08-JUL-2011 certified copies sent to parties Transmittal Letters placed on file. entered in J. & O. Book, volume 1129 page(s) 14 - 15 Interlocutory Decision

Communication to the Court from the Registry dated 07-JUL-2011 re: request for the matter to be case managed and to be held in abeyance until the final judgment is rendered in a related file.

Draft Order concerning the Plaintiff's letter (on consent with the Defendant) dated 5-JUL-2011 received on 06-JUL-2011

Letter from the Plaintiff and on consent with the Defendant dated 05-JUL-2011 asking that a case management Judge be assigned to the within action and the file be held in abeyance pending the trial judgement in Court File No. T-1668-10. (Draft order attached) received on 06-JUL-2011

Affidavit of service of Ashley Leps sworn on 27-APR-2011 on behalf of Plaintiff confirming service of doc. 4 upon Defendant by telecopier on 21-APR-2011 filed on 27-APR-2011

Reply doc. 3 on behalf of Defendant Filed on 27-APR-2011

Affidavit of service of Pamela Tuchlin sworn on 11-APR-2011 on behalf of Defendant confirming service of Doc#2 upon Plaintiff by personal service on 11-APR-2011 filed on 11-APR-2011

Defence on behalf of Defendant, AstraZeneca Canada Inc. filed on 11-APR-2011

Statement of Claim filed on 08-MAR-2011 Tariff other action - $150.00